The QualityStocks Daily Tuesday, September 16th, 2025

Today's Top 3 Investment Newsletters

Green Energy Stocks(TURB) $12.4000 +359.26%

MarketClub Analysis(FGI) $9.5000 +139.29%

QualityStocks(BGI) $1.3200 +55.44%

The QualityStocks Daily Stock List

Birks Group (BGI)

TradersPro, QualityStocks, StockMarketWatch, TraderPower, InvestorPlace, MarketBeat, FreeRealTime, StockOodles, Jason Bond, BUYINS.NET, GreatStockPix, Investing Futures, OTCtipReporter, Small Cap Firm, Street Insider, StreetInsider, The Online Investor, TopPennyStockMovers and PennyStockScholar reported earlier on Birks Group (BGI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Birks Group Inc. (NYSE American: BGI) (FRA: 2BG) is a luxury retailer that is engaged in the designing, development, manufacture and retail of plated and sterling silverware, time pieces and fine jewelry, among other gifts.

The firm has its headquarters in Montreal, Canada and was incorporated in 1879, on March 1st. Prior to its name change in October 2013, the firm was known as Birks & Mayors Inc. It has stores operating in Georgia and Florida, which are both found in the U.S. as well as stores across Canada.

The enterprise operates through 2 segments: the other segment and the retail segment. The latter segment comprises of gold exchange, wholesale and e-commerce businesses while the former segment operates over 25 stores under the Maison Birks brand in Canada, another store under the Brinkhaus brand and 2 more stores under the Patek Phillippe and Graff brands. Its other segment purchases various precious metals, including gold from clients and refines the metals purchased. In addition to this, it is also involved in the wholesale and retail of fine jewelry collections via the Mappin & Webb and Goldsmiths stores. Majority of the enterprise’s revenue is generated from the retail segment. The company’s products include pearls, charms, necklaces, bracelets, earrings, wedding bands, precious metal and gemstone jewelry, among others.

Birks Group (BGI), closed Tuesday's trading session at $1.32, up 55.4404%, on 49,016,857 volume. The average volume for the last 3 months is 22,610 and the stock's 52-week low/high is $0.5606/$2.38.

Flux Power (FLUX)

QualityStocks, MarketBeat, PennyStocks24, FreeRealTime, Greenbackers, StreetInsider, Marketbeat.com, Catalyst IR, Joe Penny Stocks, Lebed.biz, Liquid Tycoon, WePickPennyStocks, Penny Stock Pick Alert, Penny Stock Pick Report, PoliticsAndMyPortfolio, PennyStockMoneyTrain, TopPennyStockMovers, Wall Street Grand, Winning Penny Stock Picks, RisingPennyStocks, Stock News Now, StockMister, Super Hot Penny Stocks, Super Nova Stock Picks, The Wall Street Transcript, Tip.us and PennyPickAlerts reported earlier on Flux Power (FLUX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Flux Power Holdings Inc. (NASDAQ: FLUX) is focused on designing, developing, manufacturing and selling lithium-ion energy storage solutions for airport ground support equipment, lift trucks, solar applications and robotic applications, as well as other commercial and industrial applications.

The firm has its headquarters in Vista, California and was incorporated in 1998, on September 21st by Michael Johnson and Christopher L. Anthony. It operates as part of the electrical equipment and parts industry, under the industrials sector. The firm serves consumers in the United States.

The company is focused on providing Li-ion energy storage solutions that help improve sustainability and ESG metrics for fleets while decreasing carbon dioxide emissions. It operates through its Flex Power Inc. subsidiary. The company offers its customers more environmentally friendly and better performing alternatives to traditional solutions.

The enterprise provides battery management systems that offer cell charging, balancing, discharging, monitoring and communication between the forklift and the pack. It also offers smart wall-mounted chargers to interface with battery management systems; and 24-volt onboard chargers for its class 3 Walkie LiFT packs. The enterprise sells its products directly to small firms and end-users, as well as through battery distributors, lift equipment dealers and original equipment manufacturers.

Flux Power (FLUX), closed Tuesday's trading session at $3.15, up 52.1739%, on 7,558,043 volume. The average volume for the last 3 months is 9,787,516 and the stock's 52-week low/high is $1.15/$3.3851.

Boxlight Corporation (BOXL)

TaglichBrothers, MarketBeat, StreetInsider, StockMarketWatch, InvestorPlace, QualityStocks, StockRockandRoll, PennyStockLocks, BUYINS.NET, MarketClub Analysis, TopPennyStockMovers, Zacks, TradersPro, Penny Stock 101, Trades Of The Day, Trading Concepts, Daily Trade Alert, The Online Investor, Penny Stock 116, Money Wealth Matters, Innovative Marketing and Penny Stock 122 reported earlier on Boxlight Corporation (BOXL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Boxlight Corporation (NASDAQ: BOXL) (FRA: 2IU) is an educational technology firm which is engaged in the development and sale of interactive educational products and services.

Boxlight Corporation was founded in 1985 by Sloan Myers and Herbert Myers and incorporated in 2014 and has its headquarters in Lawrenceville, Georgia. The firm changed its name from Logical Choice Corporation to Boxlight Corporation. The company provides support services, professional development and classroom learning technology and serves students from all over the world. It also has a partnership with CareHawk to offer audio solutions for the education market. Boxlight’s software is available in more than 33 languages and its products are sold in over 60 nations.

Boxlight Corporation mainly targets the K-12 education market and provides Interactive Instructional Software from MimioStudio which allow individuals to create, edit and present interactive instructional activities and lessons such as Whiteboarding Software and Oktopus Instructional. Other products include MimioInteract and GameZones, which is an interactive gaming software and Notes+.

The firm provides interactive flat panel displays, installation accessories, wall-mount accessories for standard and interactive projectors and amplified speaker systems. Boxlight Corporation also distributes 3D printing solutions, robotics and math data logging, engineering and technology products.

Boxlight Corporation (BOXL), closed Tuesday's trading session at $2.52, up 45.6647%, on 43,391,436 volume. The average volume for the last 3 months is 6,556,795 and the stock's 52-week low/high is $1.06/$10.65.

Tantech Holdings (TANH)

QualityStocks, Premium Stock Alerts, BUYINS.NET, TradersPro, The Online Investor, StreetInsider, MarketClub Analysis, INO.com Market Report, TraderPower, StockMarketWatch, MarketBeat, InvestorPlace and Investing Futures reported earlier on Tantech Holdings (TANH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Tantech Holdings Ltd (NASDAQ: TANH) is focused on the development and manufacture of bamboo-based charcoal products for various applications, which include cleaning, agricultural, purification, heating, household cooking and industrial energy.

The firm has its headquarters in Lishui, the People’s Republic of China and was incorporated in 2001, on November 19th by Zheng Yu Wang. The firm serves consumers across the globe, with a focus on China.

The company operates through the Electric vehicle, Trading and Consumer product segments. The electric vehicle segment is focused on the provision of electric control systems for electric cars, auto parts, Li-ion batteries and solar cells. The trading segment is focused on the exportation of charcoal products. On the other hand, the consumer product segment offers barbecue charcoal, deodorization and purification products and cleaning products developed for the domestic market. These products are sold under the Charcoal Doctor brand.

The enterprise’s other products include a liquid byproduct that can be used in fertilizers, toilet cleaners, specialized soaps, lotions, detergents and disinfectants known as bamboo vinegar. This byproduct can also be used in different agricultural applications. In addition to this, the enterprise is also involved in the development and sale of specialty electric vehicles like funeral cars, special emergency vehicles, electric cleaning cars and brushless cleaning cars, as well as electric logistics cars and electric buses.

Tantech Holdings (TANH), closed Tuesday's trading session at $2.36, up 24.8677%, on 14,184,327 volume. The average volume for the last 3 months is 659,125 and the stock's 52-week low/high is $1.4501/$10.768.

Darkiris Inc. (DKI)

We reported earlier on Darkiris Inc. (DKI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Darkiris Inc. (NASDAQ: DKI) is a holding firm focused on the development, publishing, marketing and distribution of mobile games on a range of platforms in Hong Kong, Taiwan, Southeast Asia, North America, and the Middle East.

The firm has its headquarters in Sheung Wan, Hong Kong and was incorporated in 2017. It operates as part of the electronic gaming and multimedia industry, under the communication services sector. The firm primarily serves consumers in Hong Kong.

Darkiris’ goal is to create and promote a broader array of engaging, immersive, and captivating mobile game genres for a global audience. It leverages the innovative, creative and technical expertise of Hong Kong’s gaming industry community, and the multicultural environment and diverse interests of mobile game players in the regions. The company is committed to consistently showcasing exceptional strength and unique allure across diverse gaming sectors, leading the way in pioneering advancements within the industry. Darkiris conducts its business through its subsidiaries; Quantum Arts Company Limited and Hongkong Stellar Wisdom Company Limited. Quantum is driven by a team of technically proficient developers with keen market insights.

The enterprise engages in game design, programming, and graphics activities. It also develops interactive AI experiences and cross-media content applications. Darkiris offers its products through various third-party digital storefronts.

The firm, which recently launched its IPO, remains committed to delivering innovative mobile games to its global audience, establishing a strong foothold in the global gaming market, and generating additional value for its shareholders.

Darkiris Inc. (DKI), closed Tuesday's trading session at $8.01, off by 3.494%, on 275,597 volume. The average volume for the last 3 months is 95,860 and the stock's 52-week low/high is $84.8/$227.2.

MARA Holdings Inc. (MARA)

MarketClub Analysis, CryptoCurrencyWire, BillionDollarClub, CurrencyNewsWire, Schaeffer's, QualityStocks, InvestorPlace, INO Market Report, StockMarketWatch, MarketBeat, StockEarnings, StocksEarning, Early Bird, Zacks, Premium Stock Alerts, TradersPro, Investors Underground, FreeRealTime, The Online Investor, Lebed.biz, BUYINS.NET, InvestorsUnderground, Trades Of The Day, Eagle Financial Publications, 360 Wall Street, TraderPower, The Street, Daily Trade Alert, Marketbeat.com, PoliticsAndMyPortfolio, DailyMarketAlerts, Wall Street Mover, TopPennyStockMovers, StreetAuthority Daily, AllPennyStocks, Wealth Insider Alert, The Wealth Report, Earnings360, MarketClub Options, FeedBlitz, Investment House, Kiplinger Today, Stock Beast, ProsperityPub, Barchart, RedChip, Wealth Daily, Rick Saddler, TradingPub, Trading Pub, Stock Analyzer, DividendStocks, StreetInsider, Top Pros' Top Picks, StockReport, Lance Ippolito, Earnings361, Jeff Bishop, Promotion Stock Secrets, Inside Trading, StockOodles, Investment News Daily, Street Insider and DreamTeamNetwork reported earlier on MARA Holdings Inc. (MARA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Bitcoin has moved from being a niche asset to a major topic in global finance, and much of that change can be linked to Michael Saylor. In August 2020, Saylor, then the CEO of MicroStrategy, took a bold step that surprised many. He invested $250 million of the company’s cash reserves into Bitcoin.

At the time, he argued that inflation and a weakening dollar made traditional cash reserves risky. This move turned out to be the spark that opened the door for corporations to start viewing Bitcoin as a serious treasury asset.

After the first purchase, MicroStrategy did not stop. The company added more Bitcoin, including $175 million, $50 million, and later $650 million funded through convertible notes. Within a short time, it had built a billion-dollar Bitcoin portfolio. Saylor explained that this was not a gamble but a way to preserve capital. He even compared Bitcoin to “Manhattan in cyberspace,” highlighting its rare and valuable qualities. Although critics warned about volatility and debt risks, the decision proved to be influential.

By 2021, Strategy had borrowed more than $2 billion to increase its Bitcoin holdings. This steady buying during both market highs and lows gave the impression that Bitcoin could be a reliable long-term store of value. The results spoke loudly.

Between 2020 and 2024, the company’s stock performed better than the S&P 500 and, at times, even better than Bitcoin itself. Investors began to see Strategy less as a software company and more as a proxy for Bitcoin investment. By early 2025, the firm owned more than 2 percent of the total Bitcoin supply, a stash worth over $50 billion.

This strategy encouraged other institutions to follow. In just the first five months of 2025, companies and large investors spent more than $25 billion on Bitcoin. When Strategy bought 10,100 BTC worth over a billion dollars in June 2025, it further confirmed its leadership in corporate adoption. On-chain data showed coins being pulled from exchanges into cold storage and whale wallets continuing to grow, suggesting a tightening supply.

At the same time, Bitcoin’s price action reflected strong demand. Trading at around $116,000, Bitcoin has broken out of a recent downtrend. Technical indicators such as support near $114,000 and resistance above $119,000 show that the market leans bullish. Analysts believe prices could move toward $130,000 if the accumulation trend continues.

The story of Michael Saylor and MicroStrategy is no longer just about one company. It has created a wider conversation on how businesses should handle their cash reserves. What once seemed like a risky move is now considered a possible blueprint for the future. If more companies follow this model, Bitcoin may become not just a speculative asset but a standard tool in corporate finance.

You can bet that firms like MARA Holdings Inc. (NASDAQ: MARA) will be keeping a close eye on the way corporate entities are shifting their perception of BTC and adding it to their reserves.

MARA Holdings Inc. (MARA), closed Tuesday's trading session at $17.53, up 7.9433%, on 112,743,547 volume. The average volume for the last 3 months is 12,351,720 and the stock's 52-week low/high is $9.81/$30.28.

Eloro Resources (ELRRF)

QualityStocks, Tip.us, MissionIR, SeriousTraders, MiningNewsWire, InvestorBrandNetwork, SmallCapRelations, Tiny Gems, Stocks to Buy Now, StocksToBuyNow, SmallCapSociety, Rocks & Stocks, NetworkNewsWire, TradersPro and rocksandstocks reported earlier on Eloro Resources (ELRRF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) today reported additional assays from five definition drillholes at its Iska Iska project in Bolivia, further expanding the footprint of the Santa Barbara starter pit to approximately 800m by 500m by 500m deep. Results from holes in both the Polymetallic and Tin Domains included long higher-grade intercepts, notably 213.00m grading 0.51% tin and 25.46 g/t silver. The ongoing definition drill program has now completed 6,242m across 12 holes, with assays pending for two holes. Management emphasized that the system remains open laterally and downdip, highlighting significant potential for further expansion and resource upgrades ahead of the planned PEA.

To view the full press release, visit https://ibn.fm/IIoRb

About Eloro Resources Ltd.

Eloro is an exploration and mine-development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec. Eloro has an option to acquire a 100% interest in the highly prospective Iska Iska Property, which can be classified as a polymetallic epithermal-porphyry complex, a significant mineral deposit type in the Potosi Department in southern Bolivia. A recent NI 43-101 technical report on Iska Iska, which was completed by Micon International Limited, is available on Eloro’s website and under its filings on SEDAR. Iska Iska is a road-accessible, royalty-free property. Eloro also owns an 82% interest in the La Victoria Gold/Silver Project, located in the north-central mineral belt of Peru, some 50 kilometers south of the Lagunas Norte Gold Mine and the La Arena Gold Mine. For more information about the company, visit www.EloroResources.com .

Eloro Resources (ELRRF), closed Tuesday's trading session at $0.8366, up 0.7951807%, on 171,449 volume. The average volume for the last 3 months is 212,143,639 and the stock's 52-week low/high is $0.54/$1.21.

Glidelogic (GDLG)

We reported earlier on Glidelogic (GDLG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Glidelogic (USOTC: GDLG) announced the launch of its enhanced “RWA IPO” compliance solution, leveraging proprietary AI agents to cut months off traditional IPO timelines and reduce costs for issuers. The platform automates project analysis, compliance cross-checks, document preparation, and coordination with legal and financial partners, completing up to 90% of preparatory work. Designed to address challenges of lengthy IPO processes, high costs, and limited liquidity, the solution enables issuers to raise capital faster while providing investors with dual liquidity through SEC/FINRA-regulated ATS platforms in the U.S. and regulated digital securities markets abroad. The system also preserves a compliant pathway for uplisting to Nasdaq or NYSE.

To view the full press release, visit https://ibn.fm/XFBBN

About Glidelogic Corp.

Founded in December 2020 and headquartered in Las Vegas, Nevada, Glidelogic Corp. is committed to developing AI-based software, fintech solutions, and blockchain technology, as well as providing related consulting services. The company is dedicated to advancing research innovation through strategic academic partnerships, compute-as-equity models, and continuous large-language-model integration.

For more information, visit the company’s website at www.GlideLogic.ai

Glidelogic (GDLG), closed Tuesday's trading session at $0.728, even for the day. The average volume for the last 3 months is 10,491,448 and the stock's 52-week low/high is $0.023/$1.1.

Foremost Clean Energy (FMST)

QualityStocks, Green Energy Stocks, InvestorBrandNetwork, MiningNewsWire, MissionIR, Rocks & Stocks, Tip.Us, SeriousTraders, SmallCapRelations, SmallCapSociety, StocksToBuyNow, NetworkNewsWire, Jeff Bishop, Fierce Analyst, StockWireNews, Small Cap Firm and Broad Street reported earlier on Foremost Clean Energy (FMST), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Foremost Clean Energy (NASDAQ: FMST) (CSE: FAT) announced the start of a 20-hole, 2,500-metre diamond drill program this month at its 100%-owned Jean Lake Gold-Lithium Property near Snow Lake, Manitoba, targeting expansion of high-grade gold and lithium mineralization intersected in its 2022–2023 campaign. The program, running alongside ongoing drilling at the Murphy Lake South Uranium Property, leverages record-high gold prices and Foremost’s multi-asset model, with previous Jean Lake results including 7.5 g/t Au over 7.66m (with 102 g/t Au over 0.48m) and 1.26% Li₂O over 3.35m.

To view the full press release, visit https://ibn.fm/f1YXg

About Foremost

Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (WKN: A3DCC8) is a rapidly growing North American uranium and lithium exploration company. The Company holds an option to earn up to a 70% interest in 10 prospective uranium properties (with the exception of the Hatchet Lake, where Foremost is able to earn up to 51%), spanning over 330,000 acres in the prolific, uranium-rich Athabasca Basin region of northern Saskatchewan. As the demand for carbon-free energy continues to accelerate, domestically mined uranium and lithium are poised for dynamic growth, playing an important role in the future of clean energy. Foremost’s uranium projects are at different stages of exploration, from grassroots to those with significant historical exploration and drill-ready targets. The Company’s mission is to make significant discoveries alongside and in collaboration with Denison through systematic and disciplined exploration programs.

Foremost also has a portfolio of lithium projects at varying stages of development, which are located across 55,000+ acres in Manitoba and Quebec.

Foremost Clean Energy (FMST), closed Tuesday's trading session at $2.99, off by 0.3333333%, on 267,332 volume. The average volume for the last 3 months is 175,562 and the stock's 52-week low/high is $0.55/$5.7391.

Mixed Martial Arts Group (MMA)

QualityStocks, StocksEarning, Morning Watchlist, MarketClub Analysis, MarketBeat and Fierce Analyst reported earlier on Mixed Martial Arts Group (MMA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Mixed Martial Arts Group (NYSE American: MMA) , doing business as MMA.INC, announced the appointment of Donald Trump Jr. as Strategic Advisor to its board and management team. Trump Jr., a globally recognized business leader, will support global brand recognition and commercialization of the company’s combat sports platforms, training programs, and fan engagement infrastructure. He joins during a period of strong growth alongside prominent investor Conor McGregor, as MMA.INC advances its mission to transform more than 640 million global mixed martial arts fans into active participants in the sport.

To view the full press release, visit https://nnw.fm/KO284

About Mixed Martial Arts Group Limited

Mixed Martial Arts Group Limited (MMA.Inc) is revolutionizing the combat sports industry by driving participation and engagement across fans, athletes, coaches, and gym owners. The company operates four core business units:

  • TrainAlta: A platform that transforms MMA fans into active participants through structured training programs.
  • Hype: A marketing platform helping gym owners, coaches, and athletes grow revenue from their audiences.
  • MixedMartialArts.com: The go-to resource for MMA news, fighter data, fight schedules, and the legendary Underground forum.
  • BJJLink: A leading gym management platform designed for BJJ academies, offering tools for payment processing, marketing, student engagement, and content monetization.

With over 5 million social media followers, 530,000 user profiles, 50,000 active students, 18,000 published gyms and 800 verified gyms across 16 countries, MMA continues to transform the martial arts landscape and deliver unparalleled value to its stakeholders.

For more information, visit the company’s website at https://mma.inc/

Mixed Martial Arts Group (MMA), closed Tuesday's trading session at $1.69, off by 4.5198%, on 1,831,808 volume. The average volume for the last 3 months is 322,930 and the stock's 52-week low/high is $0.6/$4.11.

Bit Mining Ltd. (BTCM)

CryptoCurrencyWire, CurrencyNewsWire, QualityStocks, StockEarnings, MarketClub Analysis, Schaeffer's, Eagle Financial Publications, 360 Wall Street, FreeRealTime, 247 Market News, MarketBeat, Wall St. Warrior, smartmoneytrading, StocksEarning, The Stock Dork and INO Market Report reported earlier on Bit Mining Ltd. (BTCM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Crypto fundraising in August totaled $1.9 billion, marking a 30% decline from the $2.67 billion raised in July, according to data from DefiLlama.

Even with the slowdown, venture capital activity for the month was fairly consistent with July’s levels, largely supported by PUMP’s $600 million public token sale.

Decentralized finance (DeFi) protocols took the lead in fundraising during August. Some of the standout rounds included $50 million raised by Portal, $40 million secured by M0 in the Series B round, and a $20 million strategic investment into aPriori. Investor interest stayed steady across trading platforms and infrastructure development, showing that institutions remain committed despite overall market volatility.

The third-quarter fundraising has already edged past second-quarter totals. With $4.57 billion raised in only two months, the figure is slightly above the $4.54 billion secured in the entire previous quarter.

DefiLlama’s data also highlights how the industry has shifted compared to early 2022, when monthly raises peaked at around $7 billion. While the pace has slowed since then, experts believe this reset helps create a more balanced environment for both project builders and long-term investors.

Artificial intelligence protocols drew significant investment as well. Everlyn raised $15 million, and several AI-related projects completed early-stage funding rounds.

The overlap between AI and crypto continues to attract venture interest, particularly in areas like computing solutions and decentralized data handling.

Cybersecurity also stood out, with IVIX’s $60.1 million Series B becoming the biggest conventional venture capital deal of August. Stablecoin infrastructure also saw momentum, with Rain completing a $58 million funding round.

Payment systems were another category that pulled in diverse capital. OrangeX landed $20 million in Series B financing, alongside a number of smaller deals aimed at merchant payment tools and cross-border transfers. Growing adoption of cryptocurrency in commercial settings is fueling momentum in this sector.

The gaming space also maintained visibility, with Overtake securing $7 million for blockchain-based game development. More projects in this area are experimenting with token-driven economies and interactive gameplay mechanics.

Unlike July, August lacked a blockbuster token launch like Pump.fun’s, which impacted totals from public token sales. Community-driven offerings brought in about $30.7 million in seven projects, including $6.7 million from Lombard and approximately $11 million combined from Almanak’s two raises. The sales highlight how communities can directly back projects without heavy reliance on institutional capital.

Layer-2 platforms also advanced with targeted investments. Bitlayer secured $5 million through token sales, while Hemi Labs raised $15 million.

Overall, the third quarter reflects ongoing institutional commitment despite month-to-month fluctuations.

As more funds pour into the crypto space, the industry will deepen its reach in different industries and companies like Bit Mining Ltd. (NYSE: BTCM) could see an uptick in investor interest in their stock.

Bit Mining Ltd. (BTCM), closed Tuesday's trading session at $2.89, up 3.2143%, on 453,124 volume. The average volume for the last 3 months is 1,179,957 and the stock's 52-week low/high is $1.22/$8.0699.

Tilray Brands Inc. (TLRY)

QualityStocks, Schaeffer's, StockEarnings, InvestorPlace, CannabisNewsWire, StocksEarning, The Street, MarketClub Analysis, MarketBeat, Trades Of The Day, Daily Trade Alert, StockMarketWatch, Kiplinger Today, StreetInsider, The Online Investor, Wealth Insider Alert, Market Intelligence Center Alert, Zacks, BUYINS.NET, Investopedia, Early Bird, Premium Stock Alerts, CFN Media Group, CNBC Breaking News, INO Market Report, StreetAuthority Daily, The Street Report, Daily Profit, Earnings360, FreeRealTime, Top Pros' Top Picks, The Night Owl, InsiderTrades, Inside Trading, Prism MarketView, InvestmentHouse, Trading For Keeps, The Rich Investor, Tip.us, Trading Concepts, Investment House, AllPennyStocks, Daily Wealth, Eagle Financial Publications, Money Morning, wyatt research newsletter, Wealth Daily, VectorVest, TradersPledge, TipRanks, TheTradingReport, StrategicTechInvestor, Stock Up Featured, MarketClub, Outsider Club, Investors Alley, 360 Wall Street, Marketbeat.com, Market Munchies, Louis Navellier, Jim Cramer, Jason Bond, InvestorsUnderground, InvestorsObserver Team and Rick Saddler reported earlier on Tilray Brands Inc. (TLRY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Texas Lieutenant Governor Dan Patrick has issued a statement criticizing Governor Greg Abbott’s recent executive order on THC, saying it creates the impression that the state has endorsed the existing THC market. 

Patrick stated that his dispute with the governor is not personal but centered on policy. He noted that while he and Abbott have worked together on many issues, they remain far apart on THC regulation. 

According to Patrick, the order has been widely interpreted by the hemp and THC industry as a green light from the state. He pointed to public statements from business groups celebrating the decision as a major victory, arguing it legitimizes products that remain dangerous and often mislabeled. 

“These are the same companies that have been marketing to minors and opening shops near schools,” Patrick said. He added that many of the products on the shelves are still illegal and, in some cases, carry ingredients not disclosed to buyers. 

He warned that the governor’s action could pave the way for recreational cannabis use, despite Abbott’s repeated claims that legalization is not on the table. He emphasized that the Legislature has never voted to approve recreational cannabis. Instead, he said businesses have exploited loopholes in hemp laws to flood the market with high-potency products, now available in thousands of stores across Texas. 

The lieutenant governor noted that Senate Bill 3, passed earlier in the year, would have banned such products outright, but the measure was vetoed. He said only a full ban can protect children since age limits on alcohol and tobacco have not prevented underage use. He also cited undercover police footage from Dallas showing smoke shop employees cautioning customers that overdosing on certain THC products could be deadly. 

Patrick explained that during a special session, state leaders tried but failed to reach an agreement on safe limits for THC potency, serving size, and retail sales. Without clarity on those points, he said, lawmakers could not support moving forward. 

He further argued that the governor’s order leaves major gaps. It does not stop the sale of synthetic variants such as Delta-8 or Delta-10, nor does it restrict the sale of potent Delta-9 products. He also faulted the order for allowing stores to remain near schools and for leaving enforcement responsibilities to already stretched law enforcement agencies. 

Patrick further rejected claims in the order that states cannot ban THC under federal law. He pointed to multiple federal court rulings confirming states’ authority to impose bans and added that Congress is currently considering a nationwide prohibition on consumable THC. 

The lieutenant governor closed his statement by reaffirming his support for the state’s Compassionate Use Program, which allows doctors to prescribe THC for medical purposes, as well as for legal CBG and CBD products. But he warned against what he sees as a path toward broader legalization. “We do not want to follow Colorado’s example,” he said, adding that he remains open to further discussions with the governor. 

The debates surrounding the way to regulate hemp-sourced THC products in different jurisdictions will be closely watched by marijuana companies like Tilray Brands Inc. (NASDAQ: TLRY) (TSX: TLRY) as it could have diverse implications for the legal marijuana industry. 

Tilray Brands Inc. (TLRY), closed Tuesday's trading session at $1.22, up 3.3898%, on 37,943,006 volume. The average volume for the last 3 months is 309,999 and the stock's 52-week low/high is $0.3507/$1.88.

The QualityStocks Company Corner

D-Wave Quantum Inc. (NYSE: QBTS)

The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).

D-Wave is hosting a quantum computing user conference called Qubits Japan 2025 in Tokyo on September 17, 2025.

The event is themed "Quantum Realized" and will feature presentations highlighting customer success stories, technical roadmap updates, scientific achievements and advancements in quantum AI.

This follows an 83% increase in bookings for D-Wave's annealing quantum computing technology in the Asia Pacific region as organizations develop optimization and quantum AI applications

D-Wave Quantum Inc. (NYSE: QBTS) ("D-Wave" or "The Company"), a leader in quantum computing systems, software, and services, recently announced that it is hosting its first-ever Qubits Japan 2025 quantum computing user conference in Tokyo on September 17 to support growing interest and adoption of annealing quantum computing technology across the Asia Pacific ("APAC") region.

D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.

D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).

D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.

D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.

Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.

Advantage™ Quantum Computer

 

With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.

D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.

That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.

Leap Quantum Cloud Service

 

D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.

Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.

Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.

D-Wave Launch

D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.

From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.

Target Verticals

While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:

  • Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
  • Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
  • Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.

Market Opportunity

The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.

Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.

D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.

D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.

Leadership Team

Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.

John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.

D-Wave Quantum Inc. (NYSE: QBTS), closed Tuesday's trading session at $18.98, up 3.6026%, on 39,742,598 volume. The average volume for the last 3 months is 34,248,275 and the stock's 52-week low/high is $0.8724/$20.56.

Recent News

Clene Inc. (NASDAQ: CLNN)

The QualityStocks Daily Newsletter would like to spotlight Clene Inc. (NASDAQ: CLNN).

Clene Inc. reported new preclinical data on its drug candidate CNM-Au8 for Parkinson's disease.

The therapy improved mitochondrial health, restored cellular metabolism, reduced inflammation, and normalized gene expression in dopaminergic neurons.

Findings were presented at the Michael J. Fox Foundation's H2 Therapeutics Stewardship Meeting in New York City.

CNM-Au8 previously showed positive energetic and metabolic effects in a Phase 2 Parkinson's trial, aligning with the new preclinical results.

The treatment demonstrated no toxicity in neuronal models, consistent with safety data from over 1,000 patient-years in ALS and MS trials.

Clene plans to design a Phase 2 clinical study for Parkinson's disease while advancing ALS and MS programs.

Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, has presented encouraging preclinical findings for its lead investigational therapy, CNM-Au8, in Parkinson's disease. The data, announced earlier in September 2025, highlight the drug's potential to address key cellular and energetic deficits that drive disease progression ( https://ibn.fm/EECHU ).

UCLA researchers have developed a smart pen that can detect Parkinson's during its early stages when the symptoms relied upon for the usual way to diagnose it haven't shown up yet. Initial tests of this pen revealed an accuracy rate of 96.22%. Currently, Parkinson's is usually detected when it has advanced so much that it is difficult for existing medications to have any impact in slowing down its progression. This smart pen developed by the UCLA researchers offers an affordable and accessible way to leverage simple acts like writing on a piece of paper to detect the disease long before it manifests the signs doctors usually rely upon to diagnose the progressive condition. This pen offers transformative opportunities in PD detection since it is simple to make and use, is self-powering and can therefore be used in remote areas, can be used quickly to assess lots of people in a non-invasive way, and has a unique ability to detect the disease long before signs can be detected by any of the tests doctors have been relying on to diagnose the disease.. The researchers plan to conduct more extensive clinical trials to fine-tune this pen and then widen the scope of the neurological conditions it can detect. The widespread use of such simple tools would make any treatments commercialized by entities like Clene Inc. (NASDAQ: CLNN) of better use against Parkinson's if the disease is caught early. 

Clene Inc. (NASDAQ: CLNN) is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple sclerosis (MS).

Its lead drug candidate is CNM-Au8®, an oral suspension developed to restore neuronal health and function by increasing energy production and utilization by driving critical cellular energy producing reactions that enable neuroprotection and remyelination to increase neuronal and glial resilience to disease-relevant stressors. CNM-Au8 is being studied in various clinical trials, including the Harvard/MGH Healey ALS Platform clinical trial for patients with ALS; RESCUE-ALS, a completed proof-of-concept clinical trial in patients with early symptomatic ALS; the REPAIR trials, completed target engagement clinical trials showing brain energy metabolite change with CNM-Au8; and a completed MS clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing MS. The company also has a nanotherapeutic platform of drug discovery.

CNM-Au8

CNM-Au8, Clene’s lead asset, is a highly concentrated aqueous suspension of catalytically active, clean-surfaced, faceted gold nanocrystals. Multiple pathogenic insults contribute to neuronal death. Mitochondrial dysfunction and NAD+ decline is a common final pathway in neurodegeneration, with NAD+ as a critical determinant of cell survival and function. CNM-Au8’s catalytic mechanisms target the energetic deficits, oxidative stress and accumulation of misfolded proteins that are common to many neurodegenerative diseases.

The unique catalytic mechanism of action of CNM-Au8 is hypothesized to act as a neuroprotective and remyelinating therapy in neurodegenerative disease states in order to: (1) drive, support and maintain beneficial metabolic and energetic cellular reactions within diseased, stressed and/or damaged cells, (2) directly catalyze the reduction of harmful, reactive oxygen species (“ROS”) and (3) promote protein homeostasis via activation of the heat shock factor-1 pathway, recognized to dampen the cytotoxicity caused by misfolded and denatured proteins, which are known to occur ubiquitously in neurodegenerative diseases.

CNM-Au8 is used in combination with other agents, has no known drug-drug interactions, and is designed to improve function and survival. The clinical effects of both function and survival were seen in its clinical ALS trials, as earlier announced.

More than 500 estimated years of collective exposure across ALS, MS, and Parkinson’s disease participants in CNM-Au8 clinical trials and Expanded Access Protocol (compassionate use) programs have been recorded without any observed safety signals.

CNM-Au8 is a federally registered trademark of Clene Inc. Clene, based in Salt Lake City, Utah, with R&D and manufacturing operations in Maryland, began in 2013.

Market Opportunity

ALS is the most prevalent adult-onset progressive motor neuron disease, affecting approximately 30,000 people in the U.S. and an estimated 500,000 people worldwide, with a life expectancy of typically three to five years. Clene estimates that global ALS treatment sales will be greater than $1 billion annually within the coming few years. Additional treatments affecting daily function and survival remain the market need.

Additionally, there are more than 2 million MS patients globally, and Clene estimates the market size to be worth more than $23 billion annually. While the MS community has been successful at limiting relapses, non-relapsing MS patients continue to clinically deteriorate even while receiving effective immunomodulatory disease-modifying therapies (“DMTs”). A critical unmet medical need remains for therapeutic interventions that protect neuronal function and myelin health independent of immunomodulation to address progression independent of relapse activity.

Management Team

Robert Etherington is President, Director and CEO of Clene. He has more than 30 years of sales, marketing and leadership experience in the pharmaceutical industry. Prior to joining Clene, he worked at Actelion Pharmaceuticals, the largest biopharma company in the European Union prior to its acquisition by Johnson & Johnson in 2017, where he led that company’s U.S. commercial operations. He began his pharmaceutical sales and marketing career at Parke-Davis, a division of Pfizer, where he rose to the position of Team Leader overseeing the drug Lipitor.

Mark Mortenson is Chief Science Officer at Clene. He is co-inventor of the technology platform developed to produce the company’s therapeutics. He is the inventor or co-inventor on 32 other U.S. patents and hundreds of corresponding international patents. He is a former chief patent counsel responsible for 5,500 U.S. and international patents and patent applications. He holds bachelor’s degrees in physics and ceramic engineering from Alfred University, a master’s degree in materials science from Penn State University and a J.D. from George Washington University.

Benjamin Greenberg, M.D., MHS, FAAN, is Head of Medical at Clene. He is an internationally recognized expert in disorders of the central nervous system. He is currently professor of neurology and Vice Chair of Clinical and Translational Research in the department of Neurology at University of Texas Southwestern Medical Center in Dallas. He holds a bachelor’s degree from Johns Hopkins, a master’s degree in molecular microbiology and immunology from the Johns Hopkins School of Public Health and graduated from Baylor College of Medicine. He served residency in neurology at The Johns Hopkins Hospital.

Morgan R. Brown is CFO at Clene. He has more than 30 years of finance and accounting experience, with 23 years at biotech, pharmaceutical and medical device companies. He has served in similar roles at Lipocine Inc., Innovus Pharmaceuticals, World Heart Corp., Lifetree Clinical Research and NPS Pharmaceuticals Inc. He previously worked at accounting firm KPMG. He is a CPA with a bachelor’s degree in accounting from Utah State University and an M.S. in business administration from the University of Utah.

Clene Inc. (NASDAQ: CLNN), closed Tuesday's trading session at $6.33, up 1.28%, on 60,466 volume. The average volume for the last 3 months is 113,340 and the stock's 52-week low/high is $2.2801/$7.1.

Recent News

Lantern Pharma Inc. (NASDAQ: LTRN)

The QualityStocks Daily Newsletter would like to spotlight Lantern Pharma Inc. (NASDAQ: LTRN).

Lantern Pharma (NASDAQ: LTRN) , an AI-driven oncology company, announced the successful completion of its Phase 1a clinical trial for LP-184 (NCT05933265), which met all primary endpoints, showing a favorable safety and pharmacokinetic profile with early signs of antitumor activity. The open-label study in 63 patients with advanced relapsed or refractory solid tumors, including GBM, demonstrated disease control in 48% of evaluable patients at therapeutic dose levels, with notable responses in DDR-deficient cancers such as NSCLC, colon cancer, thymic carcinoma, and GIST. No dose-limiting toxicities were observed, and adverse events were predominantly mild. Lantern plans to advance LP-184 into Phase 1b and Phase 2 studies targeting TNBC, NSCLC, and other DDR-deficient cancers using its RADR(R) AI platform.

To view the full press release, visit https://ibn.fm/y4dXg

Lantern Pharma Inc. (NASDAQ: LTRN) is a clinical-stage biotechnology company leveraging artificial intelligence and machine learning to redefine oncology drug development. Through its proprietary platform, RADR® (Response Algorithm for Drug Positioning & Rescue), Lantern is advancing a pipeline of precision cancer therapies. The company has gained 11 FDA Designations for its portfolio of drug candidates including: Fast Track, Orphan and Pediatric Rare Disease. The company’s data-driven approach enables rapid identification of promising drug candidates and the design of targeted clinical trials for specific patient subpopulations and cancer types.

Lantern’s vision is to transform cancer treatment by integrating large-scale genomics, AI-based biomarker discovery, and preclinical modeling to accelerate the development of oncology drugs. The company’s pipeline includes three lead small molecule candidates and an antibody-drug conjugate (ADC) program across 12 cancer indications, supported by strategic collaborations with global research institutions and clinical partners. The company has three active clinical trials enrolling patients with multiple clinical milestones expected throughout the next twelve months.

The company’s mission is centered on transforming the cost and pace of developing innovative therapies for patients with genetically defined cancers or limited treatment options. Lantern is also advancing brain and CNS cancer drug development through its wholly owned subsidiary, Starlight Therapeutics.

The company is headquartered in Dallas, Texas.

Product Portfolio

Lantern Pharma’s product pipeline consists of three lead candidates—LP-300, LP-184, and LP-284—and a preclinical ADC program. All are guided by insights from the RADR® platform, which has grown to incorporate over 200 billion oncology-specific data points.

LP-300 is in a Phase 2 trial (Harmonic™) for non-small cell lung cancer (NSCLC) in never smokers. The trial evaluates LP-300 in combination with carboplatin and pemetrexed and has shown a clinical benefit rate of 86% and an objective response rate of 43% in its initial cohort. The study is enrolling 90 patients across the U.S., Japan, and Taiwan (NCT05456256).

LP-184 is in a Phase 1a trial for advanced solid tumors and GBM (NCT05933265). The compound has received FDA Fast Track Designations for GBM and triple-negative breast cancer (TNBC), as well as four Rare Pediatric Disease Designations. Upcoming Phase 1b/2 trials are planned for TNBC (monotherapy and with olaparib) and for NSCLC patients with KEAP1/STK11 mutations in combination with nivolumab and ipilimumab.

LP-284 is currently in a Phase 1 trial for relapsed or refractory non-Hodgkin’s lymphoma (NHL) and other solid tumors (NCT06132503). The drug candidate has demonstrated complete tumor suppression in preclinical models of mantle cell lymphoma resistant to Ibrutinib and bortezomib and showed synergistic activity with rituximab in high-grade B-cell lymphoma models.

Lantern’s ADC program is based on cryptophycin conjugates and is undergoing preclinical evaluation, showing sub-nanomolar potency and improved targeting in HER2-expressing models.

The company has also launched Starlight Therapeutics, focused on CNS cancers, where STAR-001 (LP-184 for CNS cancers) is advancing toward a Phase 1b/2 trial in glioblastoma and pediatric brain cancers, including ATRT, supported by Rare Pediatric Disease Designations and preclinical validation from Johns Hopkins.

Market Opportunity

Lantern Pharma is focused on oncology indications with significant unmet medical need and multi-billion-dollar commercial potential.

  • LP-300 targets non-small cell lung cancer in never smokers, a patient population estimated at over 150,000 cases globally and representing a market opportunity exceeding $4 billion annually.
  • LP-184 is positioned for use in DDR-deficient tumors such as pancreatic, bladder, and triple-negative breast cancers, which collectively represent a U.S. market opportunity estimated at over $10 billion annually. Opportunities in targeted DDR-deficient tumors include the KEAP1/STK11 mutant NSCLC population targeted by LP-184, with a market potential of over $2 billion annually, and TNBC, which alone represents a $4 billion global market given its aggressiveness and high brain metastasis rate.
  • LP-284 is aimed at relapsed or refractory non-Hodgkin’s lymphomas, particularly mantle cell lymphoma and HGBL, within a market sized at $3.5 to $4 billion globally.
  • CNS cancers addressed by Starlight Therapeutics further expand Lantern’s reach, representing an estimated $5 billion annual global opportunity, including both adult and pediatric cancers.

Leadership Team

Panna Sharma, President, Chief Executive Officer, and Director, leads Lantern Pharma with a deep background in oncology-focused biotechnology and artificial intelligence. He is responsible for Lantern’s strategic vision and has driven the growth of its AI-powered drug development platform. Prior to joining Lantern in 2018, he served as President and CEO of Cancer Genetics Inc. (NASDAQ: CGIX), where he raised over $100 million and expanded the company from 25 to over 250 employees across multiple continents. Earlier, he founded TSG Partners and played a key role in the IPO of iXL, a digital strategy firm.

David R. Margrave, Chief Financial Officer and Secretary, has served in executive roles in life sciences for over two decades. Before joining Lantern, he held leadership positions at BioNumerik Pharmaceuticals, including President and Chief Administrative Officer. He has also been a strategic consultant to multiple biotech firms and served as Senior Legal Advisor at MedCare Investment Corporation. Mr. Margrave holds a dual degree in Economics and Petroleum Engineering from Stanford University and a J.D. from The University of Texas School of Law.

Kishor G. Bhatia, Ph.D., Chief Scientific Officer, has more than 40 years of experience in cancer biology, including leadership at the National Cancer Institute where he served as Director of the AIDS Malignancy Program and held key roles in cancer treatment and diagnosis. He has also worked as an Adjunct Investigator and consultant to biotech firms such as Reprocell and Cancer Genetics. Dr. Bhatia earned his Ph.D. in Biochemistry from the University of Mumbai and completed postdoctoral research at Johns Hopkins University. He is a Fellow of the Royal College of Pathology in the UK.

Investment Considerations
  • Lantern Pharma’s AI-driven RADR® platform integrates over 200 billion oncology-specific data points and underpins every stage of its precision oncology pipeline.
  • The company has three lead drug candidates in clinical development, targeting major oncology markets including NSCLC, TNBC, and NHL.
  • Starlight Therapeutics extends Lantern’s footprint into brain and CNS cancers, including pediatric indications supported by orphan and rare disease designations.
  • Lantern has received multiple FDA designations including Fast Track, Orphan Drug, and Rare Pediatric Disease status across its portfolio, enhancing regulatory pathways.
  • With approximately $19.7 million in cash and equivalents, the company is funded through at least mid-2026 to support pipeline advancement and platform development.

Lantern Pharma Inc. (NASDAQ: LTRN), closed Tuesday's trading session at $4.1, up 7.6115%, on 719,227 volume. The average volume for the last 3 months is 103,719 and the stock's 52-week low/high is $2.55/$6.118.

Recent News

Massimo Group (NASDAQ: MAMO)

The QualityStocks Daily Newsletter would like to spotlight Massimo Group (NASDAQ: MAMO).

Massimo Group (NASDAQ: MAMO) , a manufacturer and distributor of powersports vehicles, today announces the upcoming launch of its electric utility terrain vehicle (UTV), set to debut in 2026. This new model underscores the Company's commitment to meeting evolving customer demands and positioning itself as a competitive force in the fast-growing electric utility vehicle market. The new Electric UTV combines advanced performance features with quiet, efficient, and environmentally friendly operation. Powered by a 72V 200AH lithium battery paired with a 15KW permanent magnet synchronous motor , the vehicle offers a driving range of up to 70 kilometers per charge . The UTV also delivers real-time 4WD capability , a maximum speed of 45 km/h , and a 7-inch (optional 10-inch) touchscreen display for enhanced driver control and user experience. "The market for electric UTVs is expanding rapidly, not only among environmentally conscious consumers but also within the farm and ranch communities where quiet operation and reduced emissions are increasingly important," said David Shan , Chief Executive Officer of Massimo Group. "By entering this segment, Massimo is aligning with long-term consumer trends while creating significant growth opportunities for our Company and shareholders." The electric UTV market has seen steady adoption across outdoor, agricultural, and recreational sectors, with customers seeking vehicles that provide ease of use, reduced maintenance, and environmental benefits without compromising on capability. Massimo Group's entry into this market is designed to deliver strong value and performance to its retail and dealer partners. This model joins Massimo's expanding lineup of UTVs, ATVs, and recreational vehicles, further strengthening the Company's 2026 portfolio.

Massimo Group (NASDAQ: MAMO) is a prominent manufacturer and distributor specializing in powersports vehicles and recreational watercraft. Established in 2009, the company has built a reputation for delivering value-packed utility terrain vehicles (UTVs), all-terrain vehicles (ATVs), and on-road vehicles to both recreational enthusiasts and professionals in the agricultural sector. In 2020, Massimo expanded its offerings by launching Massimo Marine, dedicated to crafting high-quality watercraft with advanced designs and exceptional customer service.

Massimo Group is focused on sustainability. Its recent initiatives, including the introduction of the MVR Series of electric carts, highlight the company’s commitment to eco-friendly solutions that address growing consumer demand for sustainability in the powersports and marine industries.

The company’s manufacturing capabilities have also evolved significantly. Its expanded 376,000-square-foot facility in Garland, Texas, now features advanced automation, including a vehicle assembly robot line. This addition is expected to significantly enhanced production capacity and efficiency, enabling Massimo to scale its operations and better meet market demand.

Product Portfolio

Massimo Group’s product portfolio showcases its dedication to innovation and versatility. Its diverse lineup combines advanced features, sustainability, and value to meet the needs of a dynamic market.

  • Massimo Motor: This category includes a wide range of UTVs, ATVs, go-karts, and mini-bikes designed for both recreational and practical applications. Notable recent additions include the T-Boss 1000 UTV, which combines rugged performance with advanced features, and the GKD 350 All-Terrain Go-Kart, a versatile two-seater ideal for various terrains. The Buck 550-6 Crew, a six-seater UTV, further expands this lineup, providing comfort and utility for families and light-duty users at an accessible price point.
  • Massimo Marine: Specializing in pontoon and tritoon boats, this division emphasizes luxury and performance. A recent collaboration between Massimo and Vision Marine Technologies has introduced electric pontoon platforms, catering to consumers seeking eco-friendly watercraft for both commercial and recreational use.
  • Massimo Electric: Reflecting the company’s commitment to sustainability, Massimo Electric focuses on low-speed electric vehicles (LSVs) tailored for diverse applications. Recent launches include the MVR 2X Golf Cart and MVR Cargo Max Utility Cart, which deliver advanced features and versatility for recreational users and professionals in industries like farming and groundskeeping.

By combining practicality with cutting-edge design, Massimo Group seeks to set the standard in the powersports and marine industries.

Market Opportunity

The global ATV and UTV market is experiencing robust growth, with North America projected to reach approximately $9.18 billion in 2024 and expand at a compound annual growth rate (CAGR) of 7.8% to $13.37 billion by 2029, according to Mordor Intelligence. Likewise, the U.S. electric UTV and ATV powertrain market is rapidly expanding. It was valued at $2.46 billion in 2022 and is expected to grow at a CAGR of 10.2%, reaching $5.18 billion by 2030, as reported by Grand View Research.

The pontoon boat market complements this growth, driven by increased interest in leisure and marine tourism. The market size exceeded $7.9 billion in 2022 and is projected to grow at a CAGR of 8.3% through 2032, according to Global Market Insights. Massimo Marine’s introduction of electric pontoon platforms through its Vision Marine partnership is expected to position the company to effectively address this growing market segment.

With strategic partnerships and an expanding dealer network, Massimo believes it is poised to penetrate deeper into domestic and international markets. The company’s service coverage currently includes over 2,800 retail locations, 600 motor service centers, and 5,500 marine service centers, ensuring robust support and accessibility for customers. This extensive distribution network underpins Massimo’s ability to capture market share and drive sustained growth.

Leadership Team

David Shan, Founder, Chairman, and CEO, established Massimo Motor in 2009 and Massimo Marine in 2020. He has led the company through significant growth phases, including the development of diverse product lines and its public listing. Shan holds a bachelor’s degree in international trade from Qingdao Ocean University of China.

Dr. Yunhao Chen, CPA, serves as the company’s Chief Financial Officer, bringing extensive experience in capital markets, financial reporting, and corporate governance since her appointment in May 2023. She holds a Ph.D. in Accounting and an MBA in Finance from the University of Minnesota.

Michael Smith, Vice President, joined Massimo in 2019 and played a pivotal role in launching Massimo Marine. With a strong background in powersports retail and product innovation, he is dedicated to driving new product development. Smith studied International Business and Marketing at the University of California, San Diego.

Investment Considerations
  • Massimo Group operates within a large and growing total addressable market that’s projected to surpass $18 billion by 2026.
  • The company’s cost-competitive and feature-rich products, including all-electric offerings, provide a strong value proposition.
  • Recent automation initiatives at its Texas factory are expected to improve manufacturing efficiency by an estimated 50%.
  • During the first three quarters of 2024, revenue increased by 20.8% to $91.2 million compared to the same period in 2023, reflecting strong market demand and successful product launches.
  • Strategic partnerships, such as those with Vision Marine and Rural King, enhance Massimo’s market reach and growth opportunities.
  • Consistent innovation, as seen in the launches of the T-Boss 1000 and MVR Series, is expected to drive Massimo’s push to be a leader in its industry.

Massimo Group (NASDAQ: MAMO), closed Tuesday's trading session at $3, up 0.671141%, on 14,141 volume. The average volume for the last 3 months is 23,994 and the stock's 52-week low/high is $1.839/$4.6599.

Recent News

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF)

The QualityStocks Daily Newsletter would like to spotlight Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF).

Ucore Rare Metals (TSXV: UCU) (OTCQX: UURAF) announced a strategic technology collaboration with Metallium Limited (ASX: MTM; OTCQX: MTMCF) to integrate Metallium's Flash Joule Heating (FJH) technology with Ucore's RapidSX(TM) separation platform. The partnership aims to develop a modular, U.S.-based refining solution capable of processing both conventional rare earth concentrates and alternative feedstocks such as magnet scrap, e-waste, and lighting waste. Initial stages will focus on bench-scale and pilot testing to produce mixed rare earth chlorides for processing at Ucore's facilities, targeting high-value outputs including NdPr, Dy, and Tb. Executives emphasized the collaboration's potential to expand feedstock sources, enhance recovery of critical metals, and strengthen Western-aligned rare earth supply chains.

To view the full press release, visit https://ibn.fm/rNhbi

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) s a critical metals technology company developing scalable rare earth element (“REE”) refining infrastructure in North America. Originally founded in 2006 as a mineral exploration company, Ucore has since evolved into a processing technology innovator focused on commercializing its proprietary RapidSX™ platform under a $18.4 million contract from the U.S. Department of Defense, with additional support from Natural Resources Canada. The company’s flagship deployment is the Louisiana Strategic Metals Complex (“SMC”), with additional SMCs planned to follow.

Ucore’s mission is to help reestablish a domestic REE supply chain by offering competitive, modular processing solutions that reduce dependence on China. Supported by government funding, private capital, and engineering partnerships, Ucore aims to meet growing demand for rare earth oxides in electric vehicles, defense systems, and advanced energy technologies.

The company is headquartered in Halifax, Nova Scotia.

Projects & Technology

RapidSX™ Separation Technology

RapidSX™ is Ucore’s proprietary rare earth separation platform, delivering three times faster processing than traditional solvent extraction (SX) methods. Its current demonstration program in Kingston, Ontario, is being conducted under contract with the U.S. Department of Defense to prove commercial readiness for processing both heavy and light REEs. The project is also supported by Natural Resources Canada.

RapidSX™ employs a column-based design that eliminates the need for powered mixer-settlers, enabling a smaller facility footprint, quicker commissioning, and lower CAPEX and OPEX. The platform is adaptable to light and heavy REE feedstocks and is structured for modular scale-up.

The 52-stage RapidSX™ Commercial Demonstration Plant in Kingston, Ontario—operated in partnership with Kingston Process Metallurgy—has logged thousands of runtime hours and is currently processing rare earth feedstock further to the company’s U.S. Department of Defense contract. In January 2025, Ucore secured a $500,000 non-dilutive grant from Ontario’s Critical Minerals Innovation Fund to support the advancement of the Kingston facility and, in the words of Ontario Mines Minister George Pirie, “build a secure supply chain ready to fuel the technologies of tomorrow.”

Strategic Metals Complex – Louisiana

Ucore has selected an 80,800-square-foot brownfield site within the England Airpark in Alexandria, Louisiana, as the location for its first commercial rare earth refining facility. The Louisiana SMC is expected to scale from 2,000 tonnes per annum (TPA) of total rare earth oxides initially to 5,000 TPA, with potential to ultimately reach 7,500 TPA.

The facility benefits from Foreign Trade Zone (FTZ) status, reducing tariff burdens on imported inputs and enhancing logistics efficiency. In addition to these structural advantages, the state of Louisiana has outlined an incentive package valued at $15 million, including a $900,000 infrastructure grant and $360,000 in additional local support. The project is expected to create 100 family-wage jobs and has received strong support from federal and state officials.

To date, Ucore has secured $2.3 million in milestone payments under its $18.4 million OTA award from the U.S. Department of Defense. In early 2024, the company also secured C$2.16 million in private investment from Hondo Private Equity to support its commercialization efforts.

Bokan-Dotson Ridge REE Project – Alaska

Ucore maintains 100% ownership of the Bokan-Dotson Ridge heavy REE project in Southeast Alaska. A Preliminary Economic Assessment was completed in January 2013. The Alaska Industrial Development and Export Authority (AIDEA) has authorized $145 million in bond financing under SB99 (2014) to support future development.

While Bokan remains a long-term asset, Ucore continues to advance it at a measured pace, complementing its near-term focus on commercial rare earth refining and oxide production at the Louisiana SMC.

Market Opportunity

According to Grand View Research, the global rare earth elements market was estimated at $3.95 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2030. The market outlook remains strong, fueled by the growing demand for permanent magnets and catalysts in the automotive sector.

In March 2025, President Trump invoked the Defense Production Act to prioritize domestic critical mineral production, signaling a national mandate to reduce reliance on “hostile foreign powers’ mineral production.” One month later, the Chinese government enacted immediate export restrictions on seven key rare earth elements, including dysprosium and terbium, further intensifying pressure on Western nations to develop secure and independent supply chains. This underscores the strategic value of Ucore’s domestic separation infrastructure.

Leadership Team

Pat Ryan, P.Eng., Chairman and CEO, is the founder of Neocon International, a leading automotive OEM supplier. He brings over 25 years of experience in global supply chain innovation and has led Ucore since 2014 in its strategic pivot toward rare earth processing.

Peter Manuel, Vice President, CFO & Corporate Secretary, has served as Ucore’s financial lead for 14 years. Trained as a Chartered Accountant, with extensive experience across Canada, England, and Ireland, Mr. Manuel has advised public and private entities on strategic planning, treasury, and assurance.

Michael Schrider, MEng, P.E., Vice President & COO, is a multidisciplinary engineer with over 30 years of experience. He founded and operated engineering firms SAi and ABD and has overseen all phases of Ucore’s technical development since 2016.

Geoff Atkins, Vice President of Business Development, has 30 years of mining experience and was instrumental in advancing both Lynas’ Mt. Weld and Vital Metals’ Nechalacho REE operations. He brings deep operational knowledge and leads feedstock strategy at Ucore.

Investment Considerations
  • The company is closely aligned with national policy, receiving funding from both the U.S. Department of Defense ($18.4 million) and Natural Resources Canada (C$4.3 million).
  • Ucore’s RapidSX™ platform promises to deliver faster REE separation than traditional SX and is being commercialized at scale.
  • The Louisiana SMC aims to ramp to 7,500 TPA rare earth oxide production and benefits from FTZ status, DoD funding, and private equity backing.
  • Ucore’s 100%-owned Bokan-Dotson Ridge project remains a potentially valuable strategic heavy REE resource supported by a $145M AIDEA bond.
  • As China imposes REE export restrictions and the U.S. escalates domestic production policy, Ucore is positioned as a secure Western alternative.

Ucore Rare Metals Inc. (OTCQX: UURAF), closed Tuesday's trading session at $2.55, up 3.5323%, on 479,933 volume. The average volume for the last 3 months is 503,740 and the stock's 52-week low/high is $0.33/$3.1.

Recent News

Newton Golf Company Inc. (NASDAQ: NWTG)

The QualityStocks Daily Newsletter would like to spotlight Newton Golf Company Inc. (NASDAQ: NWTG).

Newton Golf Company (NASDAQ: NWTG) , a technology-forward golf company delivering performance-driven innovations through physics-based engineering, announced its management team will present at the ArcStone-Kingswood Growth Summit 2025 on Sept. 18 at The St. Regis Toronto. Chairman and CEO Greg Campbell and CFO Jeff Clayborne will highlight Newton's strong year-to-date financial results, accelerating adoption of its Motion and Fast Motion shafts on Tour, and long-term growth outlook during the Digital Transformation & Frontier Tech track.

To view the full press release, visit https://nnw.fm/nijeo

Newton Golf Company Inc. (NASDAQ: NWTG), a Sacks Parente Company, is a technology-forward golf equipment manufacturer committed to enhancing player performance through innovative design. Since its founding in 2018, the company has developed a growing portfolio of premium golf products, including putters, golf shafts, grips, and related accessories. Its proprietary advancements include the First Vernier Acuity putter, patented Ultra-Low Balance Point (ULBP) technology, weight-forward Center-of-Gravity (CG) design, and ultra-light carbon fiber putter shafts.

As part of its commitment to growth in golf shaft technologies, the company expanded its manufacturing operations in April 2022, opening a dedicated facility in St. Joseph, Missouri. This move reinforced its goal of maintaining high-quality production standards while manufacturing and assembling substantially all of its products in the United States. In addition to golf clubs and accessories, Newton Golf Company is exploring expansion into golf apparel and other product categories.

The company sells its products through multiple channels, including resellers, its direct-to-consumer website, Club Champion retail stores, and distributors in the U.S., Japan, and South Korea. Future expansion may include growth through mergers, acquisitions, or the development of complementary product lines.

Newton Golf Company is headquartered in Camarillo, California.

Products

Newton Golf Company is focused on delivering high-performance golf equipment with a strong emphasis on precision engineering and cutting-edge materials. The company’s key product lines include:

  • Newton Motion Golf Shafts: Launched in November 2023, these shafts are engineered with proprietary flex profiles designed for greater distance, reduced dispersion, and optimized performance across swing speeds. The company’s DOT system eliminates traditional shaft flex definitions, making it accessible to all golfers.
  • Gravity Putters: Introduced in October 2024, these putters incorporate patented Ultra-Low Balance Point (ULBP) technology to improve stroke consistency and tighten putt dispersion. Manufactured in the U.S., they feature premium materials such as steel, aluminum, titanium alloys, and patented magnesium face plate technology.
  • Golf Grips & Accessories: The company continues to innovate in this category, providing golfers with performance-enhancing grips and accessories to complement their clubs.

All Newton Golf Company products are manufactured with strict quality control standards to ensure precision and reliability, reinforcing the brand’s reputation for premium performance.

Market Opportunity

The global golf equipment market was valued at approximately $8 billion in 2022, with the U.S. market accounting for $2.9 billion. The golf club segment dominated the industry, representing 45.7% of total market share. Increasing participation in golf, particularly among younger players and women, is driving demand for high-quality, customizable golf equipment.

Key industry trends supporting growth include:

  • The increasing popularity of premium, high-performance golf equipment among both professionals and amateurs.
  • A shift toward customization, as golfers seek tailored products that enhance performance.
  • A growing interest in golf from younger demographics, with amateur and collegiate golfers being particularly receptive to innovation.

Newton Golf Company’s emphasis on U.S.-based manufacturing provides it with a competitive edge in terms of supply chain efficiency, quality control, and sustainability, further strengthening its position in the market.

Leadership Team

Dr. Greg Campbell, Executive Chairman and Chief Executive Officer, brings nearly 40 years of experience in emerging technologies, product development, and public company leadership. He currently serves as CEO of V-Grid Energy Systems, a California-based company focused on converting agricultural waste into renewable electricity and bio-carbon. He has successfully taken two companies public and previously managed a $1.2 billion P&L as SVP & GM at Lam Research. Campbell holds a Ph.D. in Electrical and Electronics Engineering from UCLA and a BA/MA in Engineering from Cambridge University.

Ryan Stearns, Chief Financial Officer, was appointed in 2024 and oversees financial planning and corporate strategy. He brings expertise in scaling businesses and optimizing financial performance to support the company’s growth.

Investment Considerations
  • Newton Golf Company operates in a large and expanding global golf equipment market with rising demand for high-performance products.
  • The company benefits from strong gross margins and a clear pathway to profitability as it scales its operations.
  • U.S.-based manufacturing provides strict quality control, supply chain efficiency, and faster response times to market demand.
  • An omnichannel sales strategy, including retail, e-commerce, and international distribution, enhances market reach and revenue diversification.
  • Future growth opportunities include new product lines, strategic acquisitions, and continued technological advancements in golf equipment.

Newton Golf Company Inc. (NASDAQ: NWTG), closed Tuesday's trading session at $2.02, up 4.6632%, on 265,521 volume. The average volume for the last 3 months is 160,754 and the stock's 52-week low/high is $1.35/$119.1.

Recent News

PowerBank Corporation (Cboe CA: SUNN) (FSE: GY2) (NASDAQ: SUUN)

The QualityStocks Daily Newsletter would like to spotlight PowerBank Corporation (Cboe CA: SUNN) (FSE: GY2) (NASDAQ: SUUN).

Another major smartphone manufacturer may be entering the battery electric vehicle (BEV) segment after both Apple and Xiaomi tried their hand at BEV manufacturing with varying results. While Apple spent over a decade and invested a whopping $10 billion into its electric vehicle ambitions and ultimately shut the project down without selling a single EV, Xiaomi's debut electric car was incredibly successful and the Chinese company has received hundreds of thousands of pre-orders. Samsung, the most dominant Android smartphone developer, is reportedly dipping its toes into the burgeoning electric vehicle segment, becoming the third smartphone manufacturer to include electric vehicle development in its portfolio. The South Korean electronics company already supplies battery systemssemiconductors, and display panels to automakers, and with its history of developing technology outside of its smartphone lines, is in a seemingly great position to pivot to electric vehicle manufacturing. Samsung can study how Apple and Xiaomi approached EV development to create an even more effective strategy. Furthermore, Samsung already manufactures batteries for electric cars in the American, Asian, and European markets and has invested significantly in solid-state battery technology. Its experience developing semiconductors, chips, advanced driver assistance, infotainment, and autonomous driving systems could also make Samsung a force to reckon with if it successfully enters the EV segment. The way in which phone makers are expanding the scope of their products shows other firms like PowerBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FRA: 103) that there are really no limits as to what a company can make as long as it plans its steps carefully. 

PowerBank Corporation (NASDAQ: SUUN) (CSE: SUNN) is a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the United States. The company is committed to advancing the transition to sustainable energy by offering end-to-end services that include project origination, financing structuring, engineering, procurement, construction, and long-term operations and maintenance. PowerBank focuses on delivering innovative energy solutions through solar photovoltaic systems, battery energy storage systems (BESS), and electric vehicle (EV) charging infrastructure.

With a vision to provide scalable and reliable clean energy solutions, PowerBank has established itself as a leader in the renewable energy market by cultivating partnerships with utilities, commercial and industrial entities, municipalities, and residential customers. Its vertically integrated business model allows for optimized efficiency, cost management, and returns across diverse markets in North America. This end-to-end approach ensures greater control over project quality, costs, and operational outcomes, strengthening its competitive position.

Driven by a mission to create a greener future, PowerBank manages a robust portfolio of projects, including more than 100 megawatts (MW) of developed capacity and a pipeline exceeding one gigawatt (GW). The company’s commitment to sustainability and innovation makes it a recognized player in the renewable energy sector.

PowerBank has offices in Toronto, Ontario and New York.

Projects

PowerBank boasts an impressive and diverse portfolio of renewable energy initiatives that underline its leadership in the clean energy space. In the U.S., the company has over 250 MW of solar projects under development, principally in New York, focusing on community solar farms and commercial and industrial installations. Notably, PowerBank is developing several community solar projects in upstate New York, which will deliver clean energy to local residents and small businesses. Community solar projects, which are a cornerstone of PowerBank’s portfolio, provide scalable solutions for renters, homeowners, and small businesses to access affordable renewable energy, driving localized energy independence and economic savings.

In Canada, PowerBank has been a significant participant in Ontario’s Feed-in-Tariff program, where it has secured contracts for close to 200 MW of capacity. Its current management includes 70 solar power projects, totaling 28.8 MW of operational solar assets. The company’s expertise extends to the development and ownership of battery energy storage systems and EV charging stations, further diversifying its portfolio.

The company’s vertically integrated approach spans the entire project lifecycle, from initial site acquisition and grid interconnection to long-term operation and maintenance services. This ensures seamless execution and high-quality outcomes, providing value to stakeholders and supporting the transition to a clean energy future.

Market Opportunity

PowerBank operates within a growing renewable energy market driven by global demand for sustainable power solutions. In North America, favorable policies such as the Inflation Reduction Act in the United States and Canada’s investments in green technologies provide a robust foundation for renewable energy adoption. Solar PV installations and battery energy storage systems are at the forefront of this expansion, addressing energy reliability and grid stability while reducing carbon emissions.

The North American solar PV market was valued at $25.02 billion in 2019 and is projected to reach $120.74 billion by 2027, growing at a compound annual growth rate (CAGR) of 21.7% from 2020 to 2027. Likewise, the global BESS market is expected to expand from $7.8 billion in 2024 to $25.6 billion by 2029, at a CAGR of 26.9%, as reported by MarketsandMarkets. These trends are driven by the increasing integration of renewable energy sources, the need for grid resilience, and declining technology costs.

PowerBank’s operations have it well-positioned to capitalize on these opportunities. With a development pipeline exceeding one gigawatt (GW), the company is focused on meeting growing demand in community and commercial solar sectors. Decentralized energy solutions, such as virtual net metering and behind-the-meter systems, further enhance PowerBank’s market potential by addressing the critical need for flexible, cost-effective, and sustainable energy infrastructure. By leveraging its vertically integrated model and diversified portfolio, PowerBank stands as a key player in driving the renewable energy transition.

Leadership Team

Dr. Richard Lu, MD, MSc., MHSc., MBA, serves as President and CEO of PowerBank, bringing over 25 years of global energy experience. His leadership has been instrumental in advancing the company’s strategic initiatives across North America, Europe, and Asia, with a focus on renewable energy development and operational excellence.

Sam Sun, MBA, is the Chief Financial Officer of PowerBank. A Chartered Professional Accountant with more than 15 years of expertise in corporate finance, Mr. Sun has overseen financial strategies and internal controls across the cleantech, manufacturing, and mining sectors in Canada, the U.S., and China.

Andrew van Doorn, PE, serves as Chief Operating Officer, with nearly three decades of experience in engineering and construction. Mr. van Doorn has successfully led projects totaling over 200 MW of solar capacity and is a former Chairman of the Canadian Solar Industries Association.

Tracy Zheng, MBA, Chief Development Officer, has over 25 years of experience in brand marketing, business development, and solar project operations. She has spearheaded sales initiatives, conducted feasibility studies, and negotiated key partnerships that drive PowerBank’s growth.

Matt Wayrynen, Executive Chairman and Director, has a background in resource company management, venture capital, and mergers and acquisitions. Under his leadership, Solar Flow-Through Funds, where Mr. Wayrynen acted as CEO, was acquired by PowerBank, enhancing its asset portfolio and growth prospects.


Forward Looking Statements

This report contains forward-looking statements and forward-looking information ‎within the meaning of Canadian securities legislation (collectively, “forward-looking ‎statements”) that relate to the Company’s current expectations and views of future events. ‎Any statements that express, or involve discussions as to, expectations, beliefs, plans, ‎objectives, assumptions or future events or performance (often, but not always, through the ‎use of words or phrases such as “will likely result”, “are expected to”, “expects”, “will ‎continue”, “is anticipated”, “anticipates”, “believes”, “estimated”, “intends”, “plans”, “forecast”, ‎‎”projection”, “strategy”, “objective” and “outlook”) are not historical facts and may be ‎forward-looking statements and may involve estimates, assumptions and uncertainties ‎which could cause actual results or outcomes to differ materially from those expressed in ‎such forward-looking statements. In particular and without limitation, this report ‎contains forward-looking statements pertaining to the Company’s expectations regarding its industry trends and overall market growth of the data center market; the Company’s expansion into the data center market, including its pursuit of opportunities as a developer, owner, and strategic partner in data center infrastructure; supporting the demand for high-performance, sustainable energy solutions within the sector; details of the company’s business plan including development of solar power projects, battery storage projects and EV charging projects; the completion of any contracts for, or construction of, any data center, solar power, battery storage or EV projects; the receipt of interconnection approval, permits and financing to be able to construct projects; the receipt of incentives for projects; and the size of the Company’s development pipeline. No assurance ‎can be given that these expectations will prove to be correct and such forward-looking ‎statements included in this report should not be unduly relied upon. These ‎statements speak only as of the date of this report.‎

Forward-looking statements are based on certain assumptions and analyses made by the Company in light of the experience and perception of historical trends, current conditions and expected future developments and other factors it believes are appropriate, and are subject to risks and uncertainties. In making the forward looking statements included in this report, the Company has made various material assumptions, including but not limited to: obtaining the necessary regulatory approvals; that regulatory requirements will be maintained; general business and economic conditions; the Company’s ability to successfully execute its plans and intentions; the availability of financing on reasonable terms; the Company’s ability to attract and retain skilled staff; market competition; the products and services offered by the Company’s competitors; that the Company’s current good relationships with its service providers and other third parties will be maintained; and government subsidies and funding for renewable energy will continue as currently contemplated. Although the Company believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect, and the Company cannot assure that actual results will be consistent with these forward-looking statements. Given these risks, uncertainties and assumptions, investors should not place undue reliance on these forward-looking statements.

Whether actual results, performance or achievements will conform to the Company’s expectations and predictions is subject to a number of known and unknown risks, uncertainties, assumptions and other factors, including those listed under “Forward-‎Looking Statements” and “Risk ‎Factors” in the Company’s most recently completed Annual Information Form, and other public filings of the Company, which include: the Company may be adversely affected by volatile solar power market and industry conditions; the execution of the Company’s growth strategy depends upon the continued availability of third-party financing arrangements; the Company’s future success depends partly on its ability to expand the pipeline of its energy business in several key markets; governments may revise, reduce or eliminate incentives and policy support schemes for solar and battery storage power; general global economic conditions may have an adverse impact on our operating performance and results of operations; the Company’s project development and construction activities may not be successful; developing and operating solar projects exposes the Company to various risks; the Company faces a number of risks involving Power Purchase Agreements (“PPAs”) and project-level financing arrangements; any changes to the laws, regulations and policies that the Company is subject to may present technical, regulatory and economic barriers to the purchase and use of solar power; the markets in which the Company competes are highly competitive and evolving quickly; an anti-circumvention investigation could adversely affect the Company by potentially raising the prices of key supplies for the construction of solar power projects; foreign exchange rate fluctuations; a change in the Company’s effective tax rate can have a significant adverse impact on its business; seasonal variations in demand linked to construction cycles and weather conditions may influence the Company’s results of operations; the Company may be unable to generate sufficient cash flows or have access to external financing; the Company may incur substantial additional indebtedness in the future; the Company is subject to risks from supply chain issues; risks related to inflation; unexpected warranty expenses that may not be adequately covered by the Company’s insurance policies; if the Company is unable to attract and retain key personnel, it may not be able to compete effectively in the renewable energy market; there are a limited number of purchasers of utility-scale quantities of electricity; compliance with environmental laws and regulations can be expensive; corporate responsibility may adversely impose additional costs; the future impact of any resurgence of COVID-19 on the Company is unknown at this time; the Company has limited insurance coverage; the Company will be reliant on information technology systems and may be subject to damaging cyberattacks; the Company may become subject to litigation; there is no guarantee on how the Company will use its available funds; the Company will continue to sell securities for cash to fund operations, capital expansion, mergers and acquisitions that will dilute the current shareholders; and future dilution as a result of financings.

The Company undertakes no obligation to update or revise any ‎forward-looking statements, whether as a result of new information, future events or ‎otherwise, except as may be required by law. New factors emerge from time to time, and it ‎is not possible for the Company to predict all of them, or assess the impact of each such ‎factor or the extent to which any factor, or combination of factors, may cause results to ‎differ materially from those contained in any forward-looking statement. Any forward-‎looking statements contained in this report are expressly qualified in their entirety by ‎this cautionary statement.‎

PowerBank Corporation (NASDAQ: SUUN), closed Tuesday's trading session at $1.83, up 3.3898%, on 207,585 volume. The average volume for the last 3 months is 508,925 and the stock's 52-week low/high is $1.23/$6.43.

Recent News

Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF)

The QualityStocks Daily Newsletter would like to spotlight Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF).

Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) , a medical device company advancing imaging-based products for the detection and treatment of breast cancer, has launched a new Frequently Asked Questions page on its corporate website at www.izocorp.com/faq . The resource provides accessible information on the company's IzoView Breast CT Imaging System, development milestones, and competitive positioning, addressing topics such as breast density, imaging workflow, and comparisons with other modalities. Optimized for search and AI platforms, the FAQ page supports Izotropic's investor relations, clinical outreach, and advocacy initiatives.

To view the full press release, visit https://ibn.fm/Q0trn

Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF) is a medical device company advancing dedicated imaging solutions to improve the screening, diagnosis, and treatment of breast cancer. Focused exclusively on this clinical area, Izotropic is developing purpose-built technologies designed to address persistent limitations in conventional breast imaging. Through innovation in both device architecture and image acquisition, the company aims to enhance diagnostic confidence while improving patient experience.

Izotropic’s mission is to deliver transformative tools that empower radiologists, reduce missed cancers, and streamline clinical workflows. By introducing a next-generation imaging platform for breast cancer screening and diagnosis, the company is targeting a clear unmet need in a multibillion-dollar global market. Its vision centers on redefining how breast imaging is performed—shifting away from adaptations of whole-body scanners or 2D mammography toward a fully dedicated approach optimized for breast anatomy.

The company’s strategy is built around a singular platform with expansion potential. Izotropic is focused on commercializing its lead product through a staged pathway that includes regulatory authorization, clinical validation, and strategic investor engagement. In parallel, the company is developing educational tools and communications platforms to raise awareness among patients, clinicians, and stakeholders about the evolving role of dedicated breast imaging technologies in cancer care.

The company is headquartered in Vancouver, British Columbia, with operations in Sacramento, California.

Technology Portfolio

Izotropic’s flagship product is the IzoView Breast CT Imaging System, a dedicated breast imaging platform offering high-resolution, true 3D visualization without compression. The IzoView system was advanced from academic innovation to commercial readiness by Izotropic’s in-house team, building on exclusively licensed technology developed at the University of California, Davis to optimize diagnostic accuracy, patient comfort, and clinical workflow. IzoView integrates proprietary mechanical design, patented hardware innovations, and trade-secret software algorithms, along with AI-driven enhancements designed to improve radiologist performance.

Now in clinical-ready form and housed at Izotropic’s engineering facility in Sacramento, California, IzoView was built under an ISO 13485-compliant quality management system. It is scheduled for use in the company’s planned U.S. clinical trial for FDA market authorization. The device is also central to the company’s broader commercialization strategy, which includes platform extensions and future imaging-based product lines outlined in its recently completed 150-page business plan and financial model.

In preparation for launch, Izotropic is also rolling out strategic awareness platforms. These include a company-hosted podcast and the development of breastct.com, a new educational resource to support patients, clinicians, and stakeholders. These initiatives are designed to enhance engagement, reinforce brand positioning, and build early market traction for IzoView.

Market Opportunity

Izotropic is targeting the global breast imaging market, which is undergoing rapid innovation as healthcare providers seek more accurate, patient-friendly alternatives to traditional mammography. Current screening technologies have well-documented limitations in detecting tumors in women with dense breast tissue, a challenge IzoView directly addresses.

According to a report by MarketsandMarkets, the breast imaging market is projected to grow from $4.3 billion in 2023 to $6.6 billion by 2028, at a compound annual growth rate (CAGR) of 8.9%. Key drivers include the increasing prevalence of breast cancer, the shift toward early detection, and advances in imaging technology such as AI integration and contrast-enhanced diagnostics.

Izotropic’s licensing structure with UC Davis allows the company to pursue either FDA or CE Mark approval, offering flexibility for U.S. and international market entry. Izotropic’s go-to-market plan is supported by ongoing education efforts and a structured clinical strategy, both aligned to accelerate adoption and unlock value in a growing global market.

Leadership Team

Robert Thast, Interim CEO, is the founding executive of Izotropic and has over 30 years of experience leading public companies. He has raised over $100 million in capital, built cross-functional leadership teams, and guided early-stage ventures through public listings and strategic transitions. At Izotropic, he oversees corporate development, financing, and market strategy.

Dr. John Boone, Ph.D., Principal Founder and Director, is a Distinguished Professor of Radiology and Biomedical Engineering at UC Davis. He is a pioneer in breast CT development, having built and tested four dedicated scanners and led trials with nearly 500 women. He has held top roles in AAPM and RSNA and currently serves as Editor-in-Chief of Medical Physics.

Ralph Proceviat, CPA, CFO and Director, brings more than four decades of experience in finance, restructuring, and cross-border operations. He has served as CEO, President, and CFO across multiple sectors and has raised significant capital for both public and private ventures. He is also the founder of C-Suite-Consulting.

Dr. Younes Achkire, Ph.D., Chief Operating Officer and Lead Engineer, is the technical lead behind IzoView. He previously co-founded Zap Surgical Systems and has commercialized FDA-cleared technologies in medtech and clean energy. At Izotropic, he manages engineering, manufacturing, clinical deployment, and operational scale-up.

Investment Considerations
  • Izotropic is the only commercial entity with exclusive global rights to the Breast CT technology developed at UC Davis.
  • The company has secured regulatory alignment with the FDA and is preparing for a pivotal U.S. clinical trial.
  • IzoView offers a proprietary, patient-centric alternative to mammography for dense breast tissue imaging.
  • A comprehensive business and financial plan supports execution across clinical, regulatory, and commercial milestones.
  • Awareness campaigns, including breastct.com and a company podcast, are primed to drive engagement and investor visibility.

Izotropic Corp. (OTCQB: IZOZF), closed Tuesday's trading session at $0.3011, up 14.7048%, on 109,912 volume. The average volume for the last 3 months is 34,980 and the stock's 52-week low/high is $0.0186/$0.33.

Recent News

Oncotelic Therapeutics Inc. (OTCQB: OTLC)

The QualityStocks Daily Newsletter would like to spotlight Oncotelic Therapeutics Inc. (OTCQB: OTLC).

Oncotelic Therapeutics (OTCQB: OTLC) announced its inclusion in a NetworkNewsWire ("NNW") editorial titled "Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth" ( https://ibn.fm/WpGOO ). The piece spotlights Oncotelic's leadership in RNA-based, immunotherapy, and targeted therapeutics, addressing critical unmet needs in aggressive cancers and pediatric rare diseases. Led by chair and CEO Dr. Vuong Trieu, the company is advancing a portfolio supported by more than 500 patent applications and 75 issued patents, leveraging AI, nanomedicine, and novel clinical models to transform cancer and rare disease treatment.

To view the full press release, visit https://ibn.fm/O3Zk7

Oncotelic Therapeutics Inc. (OTCQB: OTLC) is a clinical-stage biopharmaceutical company developing RNA-based, immunotherapy, and targeted therapeutics for cancer and other underserved diseases. The company is focused on transforming outcomes for patients with difficult-to-treat and rare conditions, particularly pediatric cancers and aggressive solid tumors. Its development strategy centers on novel compound design, nanoparticle drug delivery, and the integration of artificial intelligence to accelerate discovery and regulatory workflows.

At the center of this foundation is Chairman and CEO Dr. Vuong Trieu, a prolific industry pioneer who has filed more than 500 patents with 75 issued patents across biologics, small molecules, nanoparticles, and diagnostics. Dr. Trieu co-invented Abraxane® (sold to Celgene for $2.9 billion), underscoring his track record of creating high-value therapies. Through collaborations with industry leaders and its stake in specialized joint ventures, Oncotelic is positioned to advance a diverse portfolio of oncology assets with greater speed and cost efficiency. The company also operates a proprietary AI platform, PDAOAI, which streamlines scientific writing, regulatory documentation, and data interpretation. This system is accessible to the public through a dedicated Discord server, offering real-time engagement with Oncotelic’s research ecosystem.

With expanded clinical activity and a next-generation development model, Oncotelic continues to evolve as a multi-asset innovator in precision oncology.

The company is headquartered in Agoura Hills, California.

Pipeline and Partnerships

Oncotelic’s lead candidate is OT-101, currently in a Phase 3 trial for pancreatic ductal adenocarcinoma (STOP-PC study) and evaluated in gliomas and metastatic solid tumors in combination with IL-2 and checkpoint inhibitors. The antisense molecule targets TGF-β2, a cytokine known to suppress immune responses and promote tumor growth. A Phase 1 trial combining OT-101 with IL-2 was recently completed, demonstrating safety and paving the way for combination therapies with PD-1 blockers and other immunotherapies.

Recent data have further strengthened the rationale for OT-101 in pancreatic ductal adenocarcinoma (PDAC). In June and July 2025, two peer-reviewed studies published in the International Journal of Molecular Sciences identified TGF-β2 gene expression and methylation status as significant prognostic markers in PDAC, particularly among younger patients and those with low CD8+ T-cell infiltration. High TGF-β2 expression correlated with reduced overall survival, while elevated TGF-β2 methylation was associated with improved outcomes. These findings validate TGF-β2 as a high-priority target and support the continued development of OT-101 as a precision therapy. Both studies leveraged Oncotelic’s proprietary AI-driven platform, PDAOAI, to mine and assemble multi-omic datasets, showcasing the system’s role in accelerating insight generation.

The company holds a 45% ownership stake in GMP Biotechnology Limited, a joint venture with Dragon Capital Overseas Limited. GMP Bio owns SAPU Bioscience, which is executing several pipeline programs. SAPU and Oncotelic are jointly utilizing a rapid IND platform through their partnership with Shanghai Medicilon to support regulatory filings for up to 20 drug candidates, with five INDs already underway. This collaboration is central to accelerating development of next-generation anticancer agents.

After the joint venture, Dr. Trieu, with his team, built out a state of the art and GMP-certified R&D facility in San Diego, which operates under SAPU, that manufactures clinical trial materials and supports a proprietary nanoparticle platform trademarked Deciparticle ™. This platform includes four therapeutic candidates—two of which are in late-stage manufacturing and expected to enter IND filing before the end of 2025.

Additionally, Oncotelic owns AL-101, an intranasal administered apomorphine product intended for the treatment of Parkinson’s disease, Erectile Dysfunction, and Female Sexual Disorders.

Market Opportunity

Oncotelic is targeting large and underserved therapeutic markets with significant commercial potentials. The global pancreatic cancer treatment market alone is projected to grow at a 12.3% CAGR, reaching $5.84 billion by 2030, up from $2.92 billion in 2024, according to Research and Markets. This growth is driven by increased disease prevalence, aging populations, and demand for more effective treatment options. Notably, the incidence of early-onset PDAC is rising at an estimated rate of 4% per year in the 15–34 age group, highlighting an emerging unmet need for targeted therapies among younger patients.

Beyond oncology, Oncotelic intends to develop AL-101 for Parkinson’s disease, which affects over 1 million patients in the U.S. alone and is expected to impact 1.2 million by 2030. Erectile Dysfunction and Female Sexual Dysfunction are also major global health issues, with Erectile Dysfunction affecting up to 70% of men over 60 and Female Sexual Dysfunction impacting approximately 40% of women—both with limited treatment options, particularly for patients who fail to respond to existing medications. These underserved populations offer fertile ground for innovative new therapies.

Leadership Team

Dr. Vuong Trieu is the Chairman and CEO of Oncotelic Inc. An accomplished innovator in pharmaceutical development, Dr. Trieu previously served as President and CEO of Igdrasol, where he pioneered the approval path for paclitaxel nanomedicine via a single bioequivalence trial. After Igdrasol merged with Sorrento Therapeutics, he became Chief Scientific Officer and a Board Director. He also held leadership roles at Cenomed, Abraxis, Applied Molecular Evolution, and Parker Hughes Institute. Dr. Trieu holds a Ph.D. in Molecular Microbiology, a B.S. in Botany, has published widely, and filed over 500 patent applications with 75 issued U.S. patents.

Amit Shah is the Chief Financial Officer of Oncotelic Inc. He has over 20 years of financial leadership in life sciences, including CFO roles at Marina Biotech and Igdrasol, and senior positions at ISTA Pharmaceuticals, Spectrum Pharmaceuticals, and Caraco. He also worked in consulting and ERP implementation. Mr. Shah holds a Bachelor of Commerce from the University of Mumbai, is an Associate Chartered Accountant in India, and is an inactive CPA in Colorado.

Dr. Anthony E. Maida III is the Chief Clinical Officer – Translational Medicine at Oncotelic Inc. He has over 25 years of experience advancing cancer immunotherapies and held senior roles at Northwest Biotherapeutics, PharmaNet, and Jenner Biotherapies. He has raised over $200 million for biotech firms and negotiated licensing deals with institutions such as Pfizer, Eli Lilly, and Yale. Dr. Maida holds dual B.A. degrees in Biology and History, an MBA, an M.A. in Toxicology, and a Ph.D. in Immunology, and is active in ASCO, AACR, and other scientific societies.

Investment Considerations
  • The company’s lead candidate, OT-101, is currently in a Phase 3 trial for pancreatic cancer and is advancing toward combination studies with checkpoint inhibitors.
  • A joint venture with GMP Biotechnology enables Oncotelic to conduct low-cost research and development, operate in-house GMP manufacturing, and support a rapidly expanding nanoparticle pipeline trademarked Deciparticle ™.
  • A strategic partnership with Shanghai Medicilon supports rapid IND filings for up to 20 drug candidates, significantly accelerating development timelines.
  • Oncotelic’s proprietary AI platform, PDAOAI, enhances regulatory and research workflows while offering public engagement tools for added transparency.
  • The company maintains a multi-indication pipeline spanning oncology, Parkinson’s disease, Erectile Dysfunjction and FemaleSexual Dysfunction, providing broad commercialization potentials.
  • Recent peer-reviewed publications support OT-101’s mechanism of action and spotlight TGF-β2 as a survival-linked biomarker in younger PDAC patients.

Oncotelic Therapeutics Inc. (OTCQB: OTLC), closed Tuesday's trading session at $0.0518, up 3.6%, on 134,758 volume. The average volume for the last 3 months is 67,330 and the stock's 52-week low/high is $0.017/$0.07.

Recent News

FAVO Capital Inc. (OTC: FAVO)

The QualityStocks Daily Newsletter would like to spotlight FAVO Capital Inc. (NASDAQ: FAVO).

FAVO Capital (OTC: FAVO) , a diversified financial company with operations in financial services and real estate, has appointed Zachary Graeve to its board of directors as an independent director and chair of the Nominating and Corporate Governance Committee. Graeve, an IRC-credentialed governance advisor with more than 20 years of experience in investor relations and board advisory, has guided executive teams through IPOs, acquisitions, and market transitions. His appointment strengthens FAVO's governance and capital markets strategy as the company advances plans for an uplisting to a national exchange.

To view the full press release, visit https://ibn.fm/bctvl

FAVO Capital Inc. (OTC: FAVO) is redefining the private credit and alternative lending industry through a strategic redevelopment of its operations and offerings. With a focus on leveraging financial technology and a client-centric approach, FAVO Capital empowers small to medium-sized businesses with fast, flexible, and reliable access to capital, bridging the gap left by traditional financial institutions.

Empowering Businesses, Redefining Private Credit

As part of its strategy to uplist to Nasdaq, FAVO Capital is enhancing its technology platform, operational scalability, and market positioning to meet higher regulatory standards and attract institutional investors. Headquartered in Fort Lauderdale, Florida, FAVO employs over 120 professionals across five global offices, delivering sustainable growth and value for clients and shareholders alike.

Products and Services

  • Proprietary Lending Platform and Mobile App (In Development): FAVO Capital is in the early stages of developing an advanced digital platform designed to enhance client engagement and streamline funding processes. This platform will eventually allow businesses to apply for funding products, track progress, and manage repayment efficiencies. A complementary mobile app is also being planned to provide real-time insights and tailored recommendations, laying the groundwork for an improved borrower experience.
  • Fintech-Driven Lending Solutions: FAVO Capital is exploring proprietary and third-party technology tools, including advanced analytics and algorithms, to enhance decision-making speed and reliability in the lending process.
  • Flexible Financing Options: FAVO specializes in structuring customized capital solutions tailored to the diverse needs of small business owners, offering scalable and adaptable products that evolve with changing market conditions.

Market Opportunity

The private credit market is experiencing exponential growth as traditional banks reduce their focus on small business lending. According to industry reports, the global private credit market is projected to surpass $1.5 trillion by 2025, driven by increasing demand for alternative financing options.

FAVO Capital is uniquely positioned to capture market share within this booming sector by leveraging fintech innovation to meet the needs of underserved small businesses. With a focus on efficiency, speed, and client satisfaction, FAVO addresses critical gaps in the financial ecosystem while building a platform for long-term growth.

Recent Highlights

  • Fintech Innovation: Initial investments in app development and analytics lay the groundwork for future operational efficiency and improved borrower experience.
  • Operational Scale: A global footprint with over 120 employees combines the agility of a local lender with the reach of an international financial institution.
  • Proven Growth: FAVO’s technology-driven approach has enabled consistent expansion, solidifying its reputation as a trusted partner for small businesses.

Leadership Team

Vincent Napolitano is a Founder and CEO of FAVO Capital Inc. With over two decades of experience in finance and business development, Vincent has been instrumental in building FAVO Capital into a trusted partner for businesses seeking innovative financial strategies. Prior to founding FAVO Capital, Vincent spent 25 years on Wall Street, holding key positions at prominent firms and developing expertise in structuring complex financial deals. He also served as Chief Investment Officer for multiple special purpose vehicles (SPVs), acquiring private stock in pre-IPO unicorn companies such as Facebook and Twitter.

Shaun Quin is a Founding Member and President of FAVO Capital Inc., overseeing the company’s mission to deliver innovative and efficient private credit solutions to small and medium-sized businesses. With over 20 years of global experience as a partner, investor, and director, Shaun brings a strategic and customer-focused approach to his leadership. His expertise in fostering collaboration, building high-performance cultures, and empowering businesses has positioned FAVO Capital as a trusted leader in private lending.

Vaughan Korte, CFO, brings over 15 years of global financial expertise to his role with FAVO Capital Inc. His track record includes managing financial operations for Adidas across 60 countries with budgets exceeding $500 million. Vaughan’s leadership ensures FAVO Capital remains financially resilient, aligning financial strategy with organizational goals and fostering shareholder value.

Glen Steward, Chief Strategy Officer, is a seasoned entrepreneur with over 28 years of experience in the investment and trading industries. He drives FAVO Capital’s strategic initiatives, ensuring the company remains competitive and agile in a rapidly evolving market. Glen has held directorships and board memberships across Mauritius, South Africa, and the United States. His strategic acumen has been pivotal in integrating the FAVO Group of Companies into FAVO Capital Inc., fueling growth and market leadership.

Advisory Board

Bilal Adam, Accounting & Financial Counsel, is a financial expert with over 20 years of experience, including roles as CEO of Stewards Investment Capital. His insights into bespoke investment solutions, including fixed income, equity, and digital assets, support FAVO Capital’s innovative approach to private credit.

Honorable Earnest Hart, Corporate Governance Counsel, brings decades of legal and governance experience, having served as a New York Supreme Court Judge and COO at Columbia University Medical Center. His guidance ensures FAVO Capital maintains robust corporate governance standards.

Rocco Trotta, Business Leadership and Scalability Counsel, is the co-founder of LiRo-Hill and has decades of experience scaling businesses. His expertise in organizational efficiency and talent development strengthens FAVO Capital’s ability to attract excellence across all aspects of the business.

As FAVO Capital redevelops its operations and prepares for an uplisting to Nasdaq, the company is laying the foundation to redefine private credit with emerging fintech solutions and exceptional leadership. Learn more by visiting investors.favocap.com.

Investment Considerations
  • Early-Stage Technology Development: Laying the groundwork for proprietary platforms and scalable digital tools.
  • Significant Market Opportunity: The private credit market is projected to exceed $1.5 trillion by 2025, providing exponential growth potential.
  • Scalable Business Model: Automated processes and data-driven decision-making enable rapid scaling with minimal overhead.
  • Customer-Centric Approach: FAVO’s focus on small businesses and flexible financing solutions addresses critical gaps in the financial ecosystem.
  • Experienced Leadership: A forward-thinking executive team ensures strategic growth and innovation.

FAVO Capital Inc. (OTC: FAVO), closed Tuesday's trading session at $2.95, even for the day, on 430 volume. The average volume for the last 3 months is 1,760 and the stock's 52-week low/high is $0.162/$3.28.

Recent News

Wearable Devices Ltd. (NASDAQ: WLDS)

The QualityStocks Daily Newsletter would like to spotlight Wearable Devices Ltd. (NASDAQ: WLDS).

Wearable Devices (NASDAQ: WLDS) announced its inclusion in a NetworkNewsWire ("NNW") editorial titled "AI-Powered Wearables Transform How Consumers Interact with Everyday Technology" ( https://nnw.fm/AYAOv ). The article highlights growing global demand for neural interface technologies as consumers and industries seek seamless, gesture-based control beyond touchscreens and voice assistants. Positioned at the forefront of this trend, Wearable Devices has introduced its AI-powered Mudra Band for Apple Watch and the Mudra Link platform, offering intuitive, touchless interaction across ecosystems.

To view the full press release, visit https://nnw.fm/YNuHL

Wearable Devices Ltd. (NASDAQ: WLDS) is a growth-stage technology company pioneering the next generation of human-computer interaction through AI-powered neural input wearables. Mudra, its proprietary wrist-worn technology, enables touchless, gesture-based control of digital devices, offering users a seamless, intuitive interface through subtle finger and hand movements. Since introducing its technology to the market in 2014, the company has pursued both business-to-business (B2B) and business-to-consumer (B2C) strategies through a dual-channel model.

The company believes the future of technology should begin with the human. Wearable Devices envisions decoding the human body to enable context-aware AI-powered technology that listens, learns, and adapts – to us.

The company envisions a future where human intent becomes the language of technology. Through non-invasive neural sensing and adaptive algorithms, the company enables more natural, personalized, and intuitive interactions with computers.

The company is headquartered in Yokneam Illit, Israel.

Products

Neural control has entered the market: commercially available since 2023 with the Mudra Band and already used by thousands of users worldwide. With its product line, including Mudra Band and Mudra Link, the company has introduced the world’s first wrist-worn neural interfaces, enabling intuitive, touchless control through natural micro-gestures: subtle finger movements and wrist flicks. Whether streaming media, controlling smart devices, or interacting with AR glasses, Mudra brings neural input into everyday life.

This early adoption isn’t just validation — it’s acceleration. With real users engaging in real environments, the company is learning fast, improving faster, and shaping a product that grows more refined with every interaction.

Mudra Band

Mudra Band is the company’s flagship B2C product, designed as a sleek, aftermarket accessory for the Apple Watch. It uses patented sEMG sensors to detect neural signals from the wrist and translates them into real-time digital commands. This allows users to control and streamline interactions between the iPhone, iPad, MacBook, and Apple TV using familiar micro-gestures like taps, pinches, or swipes — all without touching a screen.

The device features a high-resolution analog front end, IMU integration, adaptive machine learning, and ergonomic form factors for all-day comfort. Users can toggle between multiple Apple devices using the Mudra Band’s dedicated Apple Watch face, enabling a fully connected, touchless experience. The Mudra Band is optimized for low-latency, high-accuracy interactions and supports a wide range of digital applications. The Mudra Band received a CES 2021 Innovation Award.

Mudra Link

Mudra Link expands the company’s reach beyond the Apple ecosystem, offering compatibility with Android, Windows, and AR/XR platforms. The product includes the innovative Gesture Mapper feature, allowing users to assign personalized commands to gestures such as tap, pinch, flick, or twist. This functionality replaces or augments traditional input methods, supporting media controls, pointer input, and full directional mapping. A key feature of Mudra Link is its dual-mode input system (mouse mode or D-pad mode), empowering users to personalize control schemes across devices, operating systems, and user interfaces.

Mudra Link is recognized for its ergonomic design, lightweight build, and plug-and-play ease of use. It supports native integration with AR glasses from leading manufacturers and received a CES 2025 Innovation Award.

Mudra DevKit and Integration

In parallel with its consumer devices, Wearable Devices offers a Mudra Developer Kit (MDK) and integration program for enterprise and OEM partners. The MDK includes full-stack tools (hardware bands, SDK, APIs, and sample code) that allow developers and original equipment manufacturers to embed Mudra’s neural sensing capabilities into their own products and applications. For example, an AR headset maker can integrate Mudra’s sensors to enable native hand-gesture input, or a software developer can use Mudra’s API to track user gestures for novel interactions.

The MDK supports both Android and iOS and even provides real-time neural raw signal monitoring for research and prototyping. This B2B offering not only expands Mudra technology into new environments such as industrial automation, robotics, and gaming peripherals, but also fosters a broader ecosystem of Mudra-powered solutions. By lowering the barrier for others to adopt its AI gesture recognition engine, Wearable Devices accelerates innovation and garners strategic relationships.

The MDK and related licensing offerings illustrate Wearable Devices’ push-pull strategy: selling consumer products today, while seeding ‘Mudra inside’ into other companies’ devices tomorrow.

Market Opportunity & Strategy

Wearable Devices operates at the intersection of neural interfaces, wearable computing, and the rapidly expanding AR/XR sector. According to MarketsandMarkets, the global AR and VR market is projected to grow from $22.12 billion in 2024 to $96.32 billion by 2029, at a CAGR of 34.2%. The rising demand for natural, hands-free input methods positions neural wearables like Mudra as foundational components in spatial computing and smart environments.

Additionally, the health monitoring wearables market is gaining traction as neural biosignals become a promising data source. The company’s LMM (Large Motor Unit Action Potential Model) platform is being explored for predictive health monitoring, cognitive state tracking, and performance analytics. Government-level support, such as advocacy from the U.S. Secretary of Health and Human Services, further validates the sector’s momentum.

Combined with patent-protected technology and strategic alliances with companies like Qualcomm, TCL-RayNeo™, and Media Exceed, Wearable Devices is well-positioned to capture value across consumer, enterprise, and healthcare verticals.

The company’s phased market strategy anticipates this:

  • Phase 1 – Enthusiast Consumer Adoption: Introduce Mudra Band as an add-on for Apple Watch (tapping into a passionate user base of early adopters and tech enthusiasts). Achieve proof-of-concept and get market feedback. This phase built brand credibility and seeded a community of users.
  • Phase 2 – Expand Platform & Ecosystem: Launch Mudra Link for all users and open the Mudra SDK to developers and B2B partners. Focus on the XR/AR market and tech-savvy consumers, while enabling enterprise use-cases through the Developer Kit and strategic partnerships. The company is actively showcasing its tech to industry leaders and integrating with their platforms.
  • Phase 3 – Leverage Data & Enter New Verticals: With a growing user base, Wearable Devices is collecting an invaluable dataset of neural signals and usage patterns. If data is the new oil for AI, neural signals will power the next computing revolution — enabling machines to understand human intent in real time. This fuels its Large Motor-Unit Action Potential Model (LMM) – a bio-signal intelligence platform that continuously learns from neural data to improve accuracy and enable new applications. One major new vertical is digital health and wellness: Wearable Devices is adapting its tech to track physiological and cognitive indicators from the wrist. Because the Mudra sensors capture muscle activation signals, they can potentially detect patterns related to stress, fatigue, focus, and even early signs of health conditions before traditional symptoms appear, and Wearable Devices recently announced it is expanding LMM into predictive health monitoring and cognitive analytics. This means the company could offer solutions for workplace productivity (measuring alertness), athletic training (muscle fatigue analytics), or preventive healthcare (flagging neuromuscular irregularities) – vastly broadening its addressable market. Through monitor applications, the vision is to go from controlling devices to also understanding the user, providing actionable bio-insights. The LMM platform’s AI continuously adapts to each individual’s neural profile, enabling truly personalized and proactive applications.
  • Phase 4 – Ubiquitous Adoption via B2B Integration: Finally, Wearable Devices plans to drive mass adoption by aligning with major consumer tech players. By making its Mudra Data Platform available to enterprises, OEMs, and app developers, the company positions itself as the backbone for neural interaction services. By “laying the groundwork for the next neural frontier”, Wearable Devices is ensuring that when the tech giants move to adopt neural input, its platform is the mature, data-rich standard ready to be deployed.

Through these phased efforts, Wearable Devices balances B2C and B2B paths. It generates near-term revenues and user feedback via direct consumer product sales, while simultaneously developing long-term enterprise relationships and intellectual property value. This dual model not only diversifies revenue streams but also reinforces the technology’s credibility: consumer adoption demonstrates demand and usability, which in turn attracts enterprise interest, creating a virtuous cycle.

Leadership Team

Asher Dahan, Chief Executive Officer, co-founded Wearable Devices Ltd. in 2014 and has served as CEO and director since 2016. He is a seasoned executive with proven expertise in strategic planning, project execution, and business leadership. Asher oversees the company’s operations and resources, guiding major corporate decisions and long-term vision. Prior to founding Wearable Devices, he held engineering and leadership roles at Intel Haifa, specializing in high-speed interface validation. He holds a BSc in Electrical Engineering from Ort Braude College.

Guy Wagner, Chief Scientific Officer and President, co-founded Wearable Devices Ltd. in 2014 and has served on its board since inception. As CSO and President, Guy leads the company’s technological innovation and scientific direction. He is the main inventor behind the company’s core technology and brings multidisciplinary expertise in hardware design, biomedical signal processing, embedded programming, and sensor systems. He previously worked at Intel as a hardware engineer and holds a BSc in Electrical Engineering from Ort Braude College.

Leeor Langer, co-founder and CTO since 2016, is a leading expert in algorithms, machine learning, and signal and image processing. He has held senior R&D roles in the medical imaging and digital security sectors, including at Intel, and brings deep academic and industry experience. Leeor has authored several scientific papers and holds a BSc from the Technion and an MSc in Applied Mathematics from Tel Aviv University, graduating cum laude.

Investment Considerations
  • Wearable Devices holds a first-mover advantage in AI-powered neural input wearables, with validation from CES Innovation Awards and early adoption in key markets.
  • The company operates a dual-channel strategy that targets both consumer product sales and enterprise licensing opportunities.
  • Strategic partnerships with Qualcomm, TCL-RayNeo™, and Media Exceed support the company’s efforts to scale commercialization globally.
  • Its expanding patent portfolio includes recent U.S. approvals for gesture-based and hybrid voice control technologies, reinforcing its competitive edge.
  • With active initiatives in XR, spatial computing, and predictive health monitoring, the company is positioned to benefit from multiple high-growth sectors.

Wearable Devices Ltd. (NASDAQ: WLDS), closed Tuesday's trading session at $6.1, off by 7.4355%, on 3,184,044 volume. The average volume for the last 3 months is 18,815,084 and the stock's 52-week low/high is $1/$25.44.

Recent News

Safe Pro Group Inc. (NASDAQ: SPAI)

The QualityStocks Daily Newsletter would like to spotlight Safe Pro Group Inc. (NASDAQ: SPAI).

Safe Pro Group (NASDAQ: SPAI) was featured in a Northland Capital Markets research report that reaffirmed its Outperform rating and $13 price target. The report, authored by analyst Michael Latimore, detailed Red Cat's announcement to embed Safe Pro's small object threat detection AI into its Black Widow drone, significantly expanding its ability to detect over 150 types of small threats including landmines and unexploded ordnance.

Northland noted the integration could allow real-time battlefield threat mapping and communications without requiring drones to return to base, creating strong demand potential among military customers. The firm expects Safe Pro to generate licensing fees similar to Palantir's VNav software, with upgrade opportunities across Red Cat's Army SRR program and future drone deployments.

To view the full report, visit https://ibn.fm/cZapc

Safe Pro Group Inc. (NASDAQ: SPAI) is a mission-driven technology company delivering advanced AI-powered security and defense solutions. It is focused on serving customers in the defense, homeland security, humanitarian, law enforcement, and commercial markets where its AI, drone-based services and ballistic protective gear can synergistically deliver safety and operational efficiency.

At the heart of Safe Pro’s mission is its patented artificial intelligence (AI), machine learning (ML), deep learning and applied computer vision software technology. These tools are currently being used to rapidly detect small objects in drone-based video and imagery such as landmines and unexploded ordnance (UXO), enabling safer and more efficient field operations across global conflict and post-conflict zones and supporting efforts to improve the reliability of critical infrastructure. The company’s vision is to lead the evolution of security and threat detection through AI innovation, while its mission is to empower governments, enterprises, and humanitarian organizations with tools to respond to evolving threats at scale.

With a team of leaders and subject matter experts drawn from the defense, technology, and public safety sectors, Safe Pro Group delivers U.S.-developed next-generation AI and drone services through its Safe Pro AI and Airborne Response units and high-performance, American-made ballistic protective solutions through its Safe-Pro USA subsidiary.

The company is headquartered in Aventura, Florida.

Products

Safe Pro Group’s three business units operate across software, hardware, and field services to deliver a comprehensive suite of solutions. Each division plays a distinct role in supporting defense, humanitarian and public safety missions around the world.

Safe Pro AI

Safe Pro AI’s core AI-powered computer vision technology enables the rapid analysis of drone-based imagery to autonomously detect objects of interest. Its flagship product, SpotlightAI™ can detect and label over 150 types of explosive threats including landmines, cluster munitions, and unexploded ordnance (UXO). Built on more than two years of real-world usage in Ukraine and now including additional imagery being gathered from the Asian-Pacific region and Africa, SpotlightAI™ rapidly processes and creates high-resolution maps supported by the hyper scalability of the Amazon Web Services (AWS) cloud or detects threats in real-time locally through its OnSite Windows-based software application. Today, the platform boasts one of the world’s largest datasets built on over 1.6 million real-world battlefield images from Ukraine, identifying 28,000+ threats across more than 6,750 hectares, an area equivalent in size to Manhattan.

Airborne Response

Airborne Response is a leading provider of mission critical drone services using U.S. Government-compliant small uncrewed aircraft systems (sUAS) (drones). It serves enterprises in utilities & telecom and insurance with a full-range of drone-based critical infrastructure inspection and monitoring solutions as well as Drone-as-a-First Responder (DFR) services for law enforcement and public safety. It provides customers with actionable intelligence though data capture, analytics and processing powered by AI.

Safe-Pro USA

Safe-Pro USA manufactures ultra-premium, American-made ballistic protection systems including advanced body armor and ballistic plates as well as complete Explosive Ordnance Disposal (EOD) suits, demining aprons, and bomb blankets. All products exceed U.S. and NATO standards and are designed, engineered, and produced in the U.S., supporting customers across military, humanitarian, and law enforcement sectors.

Market Opportunity

Harnessing its patented, real-time, AI-powered processing of drone-based imagery, Safe Pro is creating a uniquely powerful ‘Next-Gen’ approach to situational awareness supporting ground-based personnel in safely completing their defense/military, humanitarian, law enforcement & commercial missions.

The global threat posed by landmines and UXO spans nearly 60 countries, affecting millions of civilians and imposing significant economic burdens, particularly in agriculture and infrastructure. In Ukraine alone, the contamination of 17 million hectares has resulted in $50+ billion in agricultural losses, with World Bank estimates projecting $30 billion needed in demining costs. According to the Landmine Monitor 2024, regions in Asia, Africa, and Latin America continue to report high casualty rates.

Safe Pro is positioned to capture a portion of the $15 billion+ global defense tech market, especially in AI-driven battlefield intelligence, drone surveillance, and threat detection. As a U.S.-based AI and defense technology provider with a HUBZone-certified manufacturing arm, Safe Pro is eligible for federal and state procurement programs, public safety grants, and critical infrastructure contracts, as well as global humanitarian demining efforts.

Leadership Team

Dan Erdberg, Chairman and CEO, brings over 20 years of experience as a C-level technology executive. He has led multiple Nasdaq listings in the drone, 5G, and satellite communications sectors, raised over $50 million in growth capital, and spearheaded Safe Pro Group’s corporate strategy and acquisitions.

Theresa Carlise, Chief Financial Officer, has more than 30 years of experience in financial leadership roles for public companies. Her expertise includes equity transactions, strategic planning, and financial restructuring. She served as Chief Financial Officer, Secretary, Treasurer and Director of various publicly traded companies within the retail, telecommunications, distribution, transportation, mortgage banking and construction sectors.

Pravin Borkar, CTO and Director (President, Safe-Pro USA), has over 30 years of experience in the engineering and manufacturing of ballistic protection systems for the U.S. Department of Defense. He has developed armor solutions for personnel and aircraft platforms including the CH-53 and Blackhawk.

Christopher Todd, President (Airborne Response), is a drone industry veteran and Certified Emergency Manager (CEM®) with more than 30 years of experience. He founded Airborne Response and is President of AUVSI Florida, with expertise in public safety drone deployment and emergency response.

Investment Considerations
  • Unique, battle-tested and patented AI image analysis technology ready for commercialization in U.S. defense and public safety markets following more than 2 years of real-world usage in Ukraine.
  • Well positioned to capitalize on U.S. military’s increased strategic focus on domestically produced drone and AI technologies through integration with currently deployed platforms such as the U.S. Army’s Tactical Assault Kit (TAK) ecosystem for military force protection.
  • The patented SpotlightAI™ platform enables real-time detection of over 150 types of mines and UXO using AI and drone imagery and is now operating at scale, creating the world’s largest datasets of real-world landmines and UXO built on more than 1.6 million battlefield images processed and 28,000 threats identified.
  • Safe Pro is addressing a global, multi-billion-dollar need for scalable defense, public safety and demining solutions.

Safe Pro Group Inc. (NASDAQ: SPAI), closed Tuesday's trading session at $7.2, off by 2.834%, on 231,855 volume. The average volume for the last 3 months is 412,246 and the stock's 52-week low/high is $1.47/$9.1599.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.